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Cancer is the second most common cause of death in the United States, with 
over 500,000 deaths expected this year.  While significant progress has been made in 
the treatment and management of cancer, challenges remain because of the complexity 
and the heterogeneous nature of the disease.  The improvement that has been seen in 
survival rates reflects advancements not only in treatment, but also in early stage 
detection and diagnostics for certain cancers.  In particular, early stage detection and 
treatment of cancer before it has metastasized to other organs has resulted in a 
dramatic improvement in patient survival rates.  One area of research that has shown 
considerable promise in further advancing diagnostics and early cancer detection is 
nanotechnology.  Specifically, semiconductor and metal nanoparticles have great 
potential to provide advanced technology platforms for ultrasensitive and multiplexed 
detection of disease markers and probe disease on the molecular level.  Because they 
are in the same size regime as biological molecules, these nanoparticles exhibit unique 
interactions with proteins, nucleic acids and other biomarkers of interest for detecting 
and diagnosing disease.  However, high-quality nanoparticles are often unsuited for use 
in complex biological environments because of their coatings and surface chemistry.   
In this dissertation, we describe the design and development of polymer-coated 
nanoparticle imaging agents for use in blood, cell and tissue diagnostic applications.  
First, low-molecular weight, amphiphilic polymers, with hydrocarbon chains capable of 
noncovalent interactions with nanoparticle surface ligands and a hydrophilic backbone to 
render the nanoparticle water soluble, were synthesized and characterized for use in 
nanoparticle coating applications.  We demonstrate that the hydrophobic and hydrophilic 
interactions between the nanoparticle surface, the amphiphilic polymer and the aqueous 
xxi 
 
solvent were able to drive the coating and water solubilization of quantum dots.  Second, 
synthesis techniques were developed using amphiphilic polymers in a one-pot method to 
make high quality nanoparticles and stabilize and encapsulate the particles for transfer 
into water.  Using the polymer functional groups as multidentate ligands, nanoparticles 
were synthesized with a high degree of size control and increased stability.  In addition, 
by performing the synthesis in a noncoordinating amphiphilic solvent such as 
polyethylene glycol, nanoparticles were immediately transferred to water with the excess 
polymer forming a water soluble coating.   
Next, nanoparticle surface charge and how it relates to the nonspecific binding of 
nanoparticles in cells, tissues and other complex biological samples was studied.  We 
have found that highly charged (negative and positive) particles exhibit significant 
nonspecific binding to biomolecules and other cellular components in biological 
environments.  By reducing the surface charge through the incorporation of hydroxyl 
functional groups, we have nearly eliminated the nonspecific binding of quantum dots in 
blood, cells and tissues.  Moreover, through crosslinking and altering the surface 
chemistry of the polymer-coated quantum dots, we have increased the stability of the 
nanoparticles while maintaining a small hydrodynamic size.  Finally, we have 
investigated the use of the low-binding, hydroxyl quantum dots in tissue staining 
applications, where nonspecific binding presents a considerable challenge to detection 
sensitivity and specificity.  A number of biomolecule conjugation techniques were 
examined for the coupling of quantum dots to antibody targeting molecules and 
preliminary staining experiments were performed. 
 In summary, this dissertation makes significant contributions to the fields of 
nanotechnology and cancer diagnostics, particularly with new polymer coatings for 
quantum dots and other nanoparticles.  Novel synthesis techniques were developed 
using multidentate amphiphilic polymers to produce water soluble nanoparticle imaging 
xxii 
 
agents in a one-pot method.  Nanoparticle surface chemistry was also explored as a 
means to improve the functionality of these imaging agents in biological environments, 
leading to a novel, non-stick hydroxyl surface chemistry for nanoparticles with utility in 
clinical applications, particularly blood, cell and tissue assays.  These advancements 
further elucidate the properties of polymer coatings and nanoparticle surfaces and 
enhance our understanding of nanoparticle interactions in clinically relevant 
environments.  The technologies developed in this work will have a significant impact on 
nanoparticle use in ultrasensitive biomarker detection in complex biological samples and 





CANCER AND THE PROMISE OF NANOTECHNOLOGY 
 
1.1 ABSTRACT 
Nanotechnology is the field of study dealing with the control of matter on the 
―nanoscale‖, where at least one dimension is between 1 and 100 nm.  Surprisingly, while 
the initial focus of this technology has been in applications ranging from energy to 
materials science, medicine is likely to be impacted most in the near future.  Indeed, a 
number of applications in diagnostics as well as therapeutics have been developed from 
these technologies, with a few now being adopted in the clinic.  Applications in cancer 
are of particular interest due to the complexity of the disease and the unique properties 
nanoparticles offer.  The ability to perform highly sensitive, multiplexed diagnostic 
assays as well as targeted drug delivery has intensified research in cancer 
nanotechnology.  Here, we explore the needs present in cancer diagnostics and 
treatment and present the potential nanotechnology offers.  
 
1.2 INTRODUCTION 
Approximately 1.4 million new cancer cases were diagnosed in 2008 in the 
United States alone with over 12 million diagnosed worldwide [1].  Cancer is the second 
most common cause of death in the US, surpassed only by cardiovascular disease, with 
over 500,000 deaths expected this year.  Although new research in this field has vastly 
expanded our knowledge of cancer and cancer biology, particularly with new insights 
into the molecular workings of the disease [2, 3], the death rate for cancer has seen only 
a moderate decrease in the past 50 years.  In contrast, other leading causes of death 
have seen dramatic reductions in their mortality rate.  In particular, the mortality rate for 
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heart disease has been reduced by over 60% compared to its value in 1950, as seen in 
Figure 1.1.  The cancer rate has decreased by approximately 10%, with a mortality rate 




Figure 1.1. Decrease in death rates for 4 major causes of morality in the United States.  
Cancer has seen only a slight decrease in death rate over the past 50 years in 
comparison to other common causes of mortality, such as heart disease. From ACS [1]. 
 
There has been a remarkably steady and rapid decline in the cardiovascular 
disease mortality rates for all ages over the past few decades, with heart disease even 
falling below the cancer rate for people under the age of 85 (Figure 1.2).  While there 
have certainly been advances in the treatment of heart disease, this rapid decline is 
likely due to a combination of advances in both therapeutics and early diagnostics, in 
addition to preventative measures.  Early stage risk factors, such as blood pressure and 
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cholesterol levels, have also been determined to help identify patients that may be at risk 
for the disease early on, when treatment or prevention is much more successful. 
 
 
Figure 1.2.  Death rates for cancer and heart disease, 1975—2004.  Heart disease 
mortality has seen a steady decline in all age groups.  Cancer mortality, however, is 
relatively steady, with a moderate decrease over the past 15 years.  From Jemal et al 
[4]. 
 
In contrast, early stage detection and prevention methods for cancer are far less 
developed.  While significant progress has been made in the treatment and 
management of the disease, substantial hurdles still remain because of its complexity 
and heterogeneous nature.  Because of new research efforts and recent advances in 
diagnostic technologies, there is an opportunity to bring the idea of ―personalized 
medicine‖ to fruition.  Personalized medicine is defined as the diagnosis and treatment of 
patients on a case-by-case basis using molecular information specific to that patient.  
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This method can be used to generate a patient-specific disease fingerprint, gleaned from 
advanced diagnostic techniques, which can guide clinicians in the diagnosis as well as 
treatment of the disease.  Although current cancer diagnostic methods merely hint at a 
patient’s underlying molecular problems, advances in nanotechnology may be the 
stimulus needed to make personalized medicine a reality. 
 
1.3 THE MOLECULAR COMPLEXITY OF CANCER 
Research in the fields of molecular and cell biology, biochemistry and medicine 
has led to many advances in our understanding of cancer and cancer biology as well as 
new avenues for enhanced treatment and better diagnostics.  However, this work has 
also exposed the very complex and heterogeneous nature of cancer, and revealed many 
hurdles to the successful diagnosis and treatment of the disease.  Increasingly, research 
efforts are being focused on studying the disease on the molecular level and 
understanding the very complex causes and pathways involved in the biology of cancer.  
Because of these efforts, therapeutics as well as diagnostics have begun to focus on the 
molecular level of the disease and are looking at a cocktail of biomarkers and 
therapeutic targets rather than a single disease marker.   
 
Acquired Traits of Cancer Cells 
 Early work in cancer biology led to the discovery of a number of cancer genes, 
divided into oncogenes and tumor suppressors, which play a crucial role in the 
regulation of cell growth in normal cells,   Mutations in these genes result in either a gain 
of function (oncogenes) or loss of function (tumor suppressor genes) and can act in 
coordination and lead to unregulated growth of the cell and cancerous behavior [5].  
More recent work has bolstered the idea that tumorigenesis is a multistep process, 
where each step reflects a genetic aberration responsible for the eventual transformation 
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of healthy cells into cancer cells.  It has been suggested that for many cancers, there are 
between four to seven rate-limiting alteration events necessary for this ultimate 
transformation [6], and pathological analysis of patient organs has revealed lesions that 
could represent the intermediate steps along the progression to invasive cancer [7].  
Together, these discoveries indicate that a series of genetic mutations in genes 
important in the regulation of cell growth lead to a gradual and progressive conversion of 
normal cells into invasive cancer cells [7, 8].  It has been hypothesized that the vast 
number of cancer types can be broadly characterized by six functional alterations that 
affect cancerous cell growth [3]: (1) self-sufficiency in growth signals, (2) insensitivity to 
growth inhibitors, (3) evasion of apoptosis, (4) limitless replication potential, (5) 
sustained angiogenesis, and (6) tissue invasion and metastasis.  
 
Independence from External Growth Signals 
 Noncancerous cells rely on growth factors or signals from their environment or 
surrounding cells to induce mitosis and proliferation.  These signals are relayed to the 
cell through an intricate pathway of receptors as well as downstream proteins that carry 
the signal and affect the cell growth pathways.  However, cancer cells are able to bypass 
these control measures and proliferate independent of external growth signals.  This can 
occur through a variety of molecular alterations, including changes in the receptor 
proteins (structure, number, or type) [9-12] or downstream signaling molecules [13-17] or 
an acquired ability to produce growth factors that are self-stimulatory [18].  In addition, 
antigrowth signals abound to maintain homeostasis in normal cells and prevent 
abnormal cell growth.  These signals are transmitted in much the same manner as 
growth signals, through receptor molecules and downstream pathways.  Many of these 
pathways are associated with the cell cycle clock [3], in particular, the retinoblastoma 
protein (pRb), p107 and p130 [19, 20], and are responsive to a number of antigrowth 
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factors, particularly TGFβ [21, 22].  Disruption of these pathways removes a layer of 
control from the normal cell cycle, allowing uncontrolled growth to proceed. 
 
Avoiding Programmed Cell Death 
 Other traits that aid in the transformation of a normal cell to a cancerous one are 
the ability to evade apoptosis and the ability to circumvent intrinsic limits on their 
multiplication.  Apoptosis is programmed cell death, a method organisms use to remove 
damaged or diseased cells in an organized manner.  A cell with DNA damage, mutations 
or alterations to other important cell pathways may ―decide‖ to undergo apoptosis via a 
pathway mediated by p53, a tumor suppressing gene, if it is beyond repair.  Loss of 
function mutations in this gene or others in the pathway can result in a cell’s ability to 
avoid programmed cell death [23-27], allowing the cell to grow unchecked.  Mounting 
evidence suggests that the disruption of the apoptosis pathway is a hallmark of most, if 
not all, types of cancer [3, 28].  However, while the traits described above decouple the 
cell from the normal signaling controls on cell growth, they are typically insufficient to 
induce cancer transformation on their own.  This is due to an independent limitation on 
the replicative potential of cells [29], known as the Hayflick limit.  Cells that break free 
from the normal growth confinements imposed by the cell cycle regulatory pathways 
invariably undergo massive cell death unless they acquire the ability to bypass the 
Hayflick limit [30].  Although the process is not completely understood, one necessary 
alteration seems to be the upregulation of telomerase, an enzyme responsible for 
maintaining the telomeres at the end of chromosomes [31].  These are believed to 






Finding New Nutrient Sources 
 As the cancer cells multiply, nutrient supply becomes a limiting factor because 
the diffusion of oxygen and other nutrients is limited across tissue.  To bypass this 
limitation, tumor cells must acquire the ability to induce the growth of blood vessels, 
enabling them to access the required nutrients.  Work over the past few decades has 
shown that growth factors, such as VEGF and FGF1/2 play a significant role in a tumor’s 
ability to recruit new blood vessels [32].  Finally, the ability of a cancer to metastasize 
and invade also allows the diseased cells to find new sources of nutrients and is 
important in determining the eventual survival rate of the patient.  Metastasis is a 
complex process involving many proteins and is thought to account for approximately 
90% of human cancer deaths [33]. 
 
Cancer Heterogeneity 
 As described above, the progression cells undergo to reach a cancerous state is 
an extremely complex process, allowing for considerable heterogeneity.  Figure 1.3 
shows a simplified schematic of some of the potential pathways involved in the 
transformation towards malignancy.  In addition to the complexity of cancer cells, tumors 
typically consist of a number of other healthy cell types, including immune and 
endothelial cells as well as fibroblasts.  This heterogeneity makes both diagnosis and 
treatment extremely complex 
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Figure 1.3. The complexity of cancer biology.  Schematic showing the complex 
molecular pathways involved in the regulation of cell growth and death (top) and the 
heterogeneous nature of tumors, consisting of cancer cells as well as immune and 





1.4 NANOTECHNOLOGY AND IMPLICATIONS FOR THERAPEUTICS AND 
DIAGNOSTICS 
One field of technology that has shown surprising promise for use in cancer 
diagnostics and therapeutics is nanotechnology [34].  It is the field of technology that 
deals with the control of matter on the ―nanoscale‖, where at least one dimension is less 
than 100 nm.  Nanotechnology is a multidisciplinary field with significant contributions 
from engineering, materials science and chemistry.  It has also been greatly influenced 
by biochemistry and molecular biology, where biomolecules are in the same size regime 
as nanoparticles, as shown in Figure 1.4.  This size similarity allows for very unique 
interactions between nanoparticles and biomolecules, such as DNA or protein, and has 
led to exciting technologies with applications in diagnostics and therapeutics as well as 
an increased understanding of cell biology.  New discoveries in nanotechnology, biology 
and medicine have led to a plethora of nanodevices with a broad range of applications in 
the biomedical field, including drug delivery vectors, biomolecule sensing and molecular 






Figure 1.4. The nano scale.  Schematic showing the size scale of objects compared to 
the nanoscale size regime.  Complex molecular machines, DNA, and proteins are on the 
same size scale as nanoparticles and exhibit unique interactions with biomolecules for 
interesting diagnostic applications. From US DOE [36]. 
 
Nano-Diagnostics 
A variety of nanoparticles have been proposed for use as in vitro and in vivo 
diagnostic contrast agents because of their unique physical properties.  In particular, 
semiconductor and metal nanoparticles have great potential to provide advanced 
diagnostic platforms for ultrasensitive and multiplexed detection of disease markers and 
probe disease on the molecular level.  Paramagnetic iron oxide nanoparticles have been 
successfully used in vivo as MRI contrast agents for the detection of metastases and 
have been shown to outperform gadolinium based techniques in some applications [37-
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40].  Gold nanoparticles have also been explored as potential imaging agents for use in 
vivo.  Preliminary studies show the particles are highly sensitive and can be optically 
detected through the skin in animal models [41].  While the use of nanoparticles for in 
vivo diagnostic applications has progressed over the past decade, significant hurdles, 
such as biodistribution and toxicity, continue to limit their utility.  This is especially true 
for nanoparticles containing toxic materials, such as quantum dots (QDs), which often 
contain cadmium, lead or mercury.  Extensive studies will be required before FDA trials 
are even considered for the in vivo use of these particles.  In vitro diagnostics, however, 
eliminates these hurdles as an issue.  As a result, significant work has been performed 
to translate these technologies from the bench to the clinic.  SERS active gold 
nanoparticles and QDs have received an incredible amount of attention and work is 
ongoing to develop new applications for the use of these particles in vitro [42-55].  
 
Nano-Therapeutics 
Cancer therapy is expected to be significantly impacted by the development of 
new nanotechnologies [56-58].  The use of nanoparticles as therapeutic carrying agents 
provides for a platform technology that can be used for the delivery of both hydrophilic 
and hydrophobic (which are difficult to administer) molecules as well as biologics such 
as proteins or nucleic acids [59-63].  The ability to load multiple drug molecules inside a 
single particle also enables the delivery of larger payloads than with simple 
administration of naked drug, providing a more effective delivery.  Nanoparticles 
themselves can also have a therapeutic effect.  Gold nanoshells have been used to heat 
tumors upon external stimulation, inducing cell death in tissues where it accumulates 
[64, 65]. 
Because of the high surface area to volume ratio for nanoparticles, a 
substantially higher loading can also be achieved.  This is particularly effective for 
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coating the nanoparticles with multiple targeting moieties, increasing the affinity of the 
nanoparticles to the targeted tissue.  In addition, the size of the nanoparticles alone 
enhances the delivery of the payload to the cancerous tissue through the EPR effect [66, 
67].  Angiogenesis in tumors leads to the formation of ―leaky‖ blood vessels, allowing 
nanoparticles to escape into the tumor environment and access the diseased cells.  
Inadequate lymphatic drainage also aids in retaining the particles in the tumor 
environment, further enhancing the accumulation of drug in the cancerous cells.  
 
1.5 DISSERTATION STRUCTURE 
This dissertation concentrates on the development of polymer-coated 
nanoparticle imaging agents for diagnostics applications and has been organized into 8 
chapters.  Each chapter focuses on a particular aspect of the development of these 
imaging agents and discusses the approaches and results in detail.  Below is a brief 
description of each chapter.   
Chapter 1- Here, we provide a brief background about cancer and current 
diagnostic technologies as well as nanotechnology and its potential to revolutionize the 
diagnostic field. 
Chapter 2- This chapter provides a detailed discussion of semiconductor 
quantum dots (QDs) and how advancements in their development will have a 
tremendous impact on the use of nanotechnology in medicine. 
Chapter 3- Here, we present the design and development of low molecular 
weight amphiphilic polymers for the coating of hydrophobic QDs and other nanoparticles 
and how these polymers affect the optical and colloidal properties of QDs in water. 
Chapter 4- In this chapter, we discuss the use of these amphiphilic polymers in 
the simultaneous synthesis and coating of QDs in a one-pot fashion as well as an in situ 
capping method for growing a passivating shell. 
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Chapter 5- This chapter focuses on the use of the amphiphilic polymers in the 
synthesis of other inorganic nanoparticles, specifically gold nanoparticles (AuNPs) and 
SERS particles. 
Chapter 6- Here, we investigate the effects of surface charge on the nonspecific 
binding of nanoparticles in tissues, cells and biological fluids.  We also discuss the 
development of a novel hydroxyl-based surface coating for the elimination of this binding 
in biological samples. 
Chapter 7- In this chapter, we investigate conjugation techniques for the 
coupling of targeting molecules to the surface of hydroxyl-QDs and their potential use in 
tissue staining applications. 
Chapter 8- Finally, we discuss potential areas for further development of these 
technologies as well as future directions of cancer nanotechnology for diagnostic as well 
as other applications. 
 
1.6 CONCLUSIONS 
Recent advances in diagnostic technologies as well as our understanding of new 
disease biomarkers have made possible the idea of ―personalized medicine‖, where a 
patient is treated based on their specific disease fingerprint, enabled by advanced 
diagnostic methods.  While this remains a challenge, it is clear that patient survival is 
significantly improved if the disease can be detected at a very early stage and known 





QUANTUM DOTS FOR USE IN BIOLOGICAL 
ENVIRONMENTS 
2.1 ABSTRACT 
Quantum dots (QDs) are nanometer-sized particles made of semiconductor 
materials which have interesting optical and electronic properties, enabling a wide array 
of unique applications.  In particular, their fluorescence properties make them ideal for 
use in a number of biological assays, where ultrasensitive detection is needed.  
Advances in QD synthesis and surface coatings have led to a dramatic increase in 
interest from the biological and biomedical community and a number of important studies 
have been conducted.  In this chapter, we discuss the synthesis of high quality QDs and 
their novel optical properties.  We also describe the current state of art for coating the 
nanoparticles and transferring them to water.  In addition, novel uses of QDs for both in 
vitro and in vivo applications are reviewed and current challenges and opportunities for 
the use of QDs in biological systems are discussed. 
 
2.2 INTRODUCTION 
Breakthroughs in the understanding of molecular and cellular biology have fueled 
the push for more advanced tools to probe cells on the molecular level.  While 
fluorescent dyes and proteins have proven to be exceptional molecular imaging agents 
[68-70], there are many applications in biology where their deficits impede discovery.  In 
particular, their tendency to photobleach under exposure to light significantly hinders 
their use in long term tracking studies in living cells [49, 71-73], although biologists have 
discovered ways to use this phenomena as an assay tool [74-76].  In addition, most 
fluorescent molecules have a relatively small stokes shift and can only emit under a 
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narrow excitation source.  These problems prevent the multiplexing of fluorescent dyes 
to a large extent.  Recent advances in nanotechnology have allowed the use of 
nanoparticles in a variety of applications, including biology and medicine.  Polymer 
based nanoparticles as well as metal particles have seen a dramatic increase in interest 
from the medical community for both therapeutic applications as well as diagnostics and 
molecular imaging.  Quantum dots (QDs) are an exciting new class of fluorescent 
nanoparticle made from semiconductor materials, such as cadmium selenide (CdSe) or 
indium arsenide (InAs), and have been used in a broad range of applications, including 
solar energy conversion[77, 78], light emitting diodes[79], displays and biomedical 
imaging[53, 80-85] and detection[42-45, 86].  This very broad interest is driven by their 
unique electronic and optical properties, including high signal brightness, resistance to 
photobleaching, and simultaneous excitation of multiple fluorescence colors [46, 48, 87, 
88], making them exceptional for use as optical imaging agents compared to traditional 
organic dyes. 
 
2.3 SEMICONDUCTOR NANOCRYSTALS 
Semiconductor nanocrystals, also know as quantum dots, are typically made of 
II-VI or III-V semiconductor materials and are generally less than 10 nm in diameter.  
Many of the unique electronic and optical properties mentioned above are the result of a 
phenomenon called ―quantum confinement‖, from which a QD derives its name.  When a 
semiconductor material is excited (for a QD, this typically involves the absorption of 
photons), electrons are able to leave the valence band and enter the conduction band at 
a higher energy level.  The electron and the hole left behind when it enters the 
conduction band form a pair called an exciton.  A material’s exciton Bohr radius is 
defined as the physical separation between the electron and the hole of the exciton.  For 
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bulk semiconductor, this is extremely small compared to the size of the material, 
allowing the exciton to move throughout the material. 
However, a QD’s size is such that it is smaller than its material’s exciton Bohr 
radius, in a size regime where the bandgap of the material can be tuned by changing the 
size of the nanoparticle.  By decreasing the nanoparticle size to below the exciton Bohr 
radius, the exciton is confined, increasing the bandgap of the nanocrystal.  This increase 
in bandgap has a direct impact on the energies involved in the production of photons 
from the material and means emitted light is at a higher energy than for the bulk 
material, resulting in light emission at a lower wavelength (blue-shifted emission).  
Because of this unique effect, the fluorescence emission color of the QDs can be tuned 
by simply altering the particle’s size, providing nanoparticles with fluorescence emission 
in the visible light range as well as the near-infrared.  CdSe QDs, the most studied for 
biological applications, has a bulk bandgap of 1.74 eV, corresponding to far red 
emission.  By decreasing the nanoparticle’s size, the fluorescence emission wavelength 
can be decreased to cover most of the visible light range, from red (particle diameter of 






Figure 2.1. Unique optical properties of quantum dots: (a) size tunable fluorescence 
emission by altered nanoparticle size (from Smith et al [89]), (b) excellent photostability 
and resistance to photobleaching as compared to organic dyes (from Gao et al [90]), (c) 
simultaneous excitation of multiple fluorescence colors spanning the entire visible range, 
allowing highly multiplexed staining of disease biomarkers (from Han et al [47]). 
 
QDs with very high quantum yields can be produced using improved synthetic 
procedures developed by our lab and others [91-94].  This, in addition to the much larger 
absorption cross-section of the QDs, results in a particle that is at least 20 times brighter 
than an organic fluorophore [95].  Resistance to photobleaching is another important 
feature that is necessary for use in clinical applications.  Unlike organic dyes, which can 
begin to photobleach immediately upon exposure to light [96], the constant fluorescence 
intensity of QDs make them ideal imaging and biosensing agents where consistent 
measurements are essential (Figure 2.1b).   
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For multiplexed assays, which are extremely important for advanced diagnostic 
applications, the ability to simultaneously excite multiple QD colors with a single 
excitation source (Figure 2.1c) makes them far superior to organic dyes and allows for 
the simultaneous measurement of multiple disease markers.  These properties, as seen 
in Figure 2.1, make QD probes well suited for multiplexed molecular profiling of intact 
cells and clinical tissue specimens in comparison to organic dyes.[54, 55, 90, 97-100]   
 
2.4 COATING STRATEGIES AND TRANSFER TO WATER 
Considerable advances have been made in the chemical synthesis and 
preparation of high quality, monodispersed QDs [91, 101, 102], especially with the use of 
organometallic and chelated cadmium precursors [103, 104], noncoordinating solvents 
[105], and inorganic passivating shells [106, 107].  These advances have led to the 
production of nanoparticles with very narrow size distributions (fluorescence emission 
FWHM < 25 nm) and high quantum yields (QY > 75%).  While the resulting QDs have 
superb physical and optical properties, the highest quality nanoparticles typically have 
hydrophobic surface ligands (Figure 2.2) are often and are unsuited for use in biological 
environments [84, 108, 109].  To address this problem, a number of surface 
encapsulation and water solubilization strategies have been used to transfer QDs to 
aqueous solvents including direct ligand exchange of the hydrophobic surface ligands 
with hydrophilic small molecules, and indirect surface encapsulation techniques using 
silica, lipids, block copolymers and low molecular weight amphiphilic polymers [53, 80, 






Figure 2.2. Schematic structure of a core-shell quantum dot with hydrodynamic surface 
ligands for stabilization.  For water solubilization, the hydrophobic ligands must either be 
coated with an amphiphilic material or exchanged for surface ligands that are 
hydrophilic. 
 
Ligand Exchange with Small Molecules 
One of the first successful methods employed to transfer hydrophobic QDs to 
water was a direct ligand exchange method [81].  This procedure entailed transferring 
the nanoparticles to a solvent capable of displacing the hydrophobic surface ligands and 
coordinating with the surface of the nanocrystals.  Thiol functional groups were found to 
strongly coordinate with the inorganic shell of the nanocrystal, making compounds 
containing these functional groups, such as mercaptoacetic acid, ideal for initial transfers 
to water.  By using small molecules for the transfer to water, the physical and 
hydrodynamic size of the nanoparticles was also kept to a minimum, as seen in Figure 
2.3, important for some biological applications.   However, QDs produced in this manner 
tend to be unstable after a matter of days, leading to particle aggregation and 
precipitation.  Further advances have been made for this transfer strategy, using other 
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functional groups to coordinate with the QD surface and ligand molecules capable of 
multivalent coordination to the surface to improve the stability of the particles [48, 110, 
111, 114].  In addition, biocompatible molecules such as amino acids, proteins, etc. have 




Figure 2.3. Quantum dot coatings and colloidal properties (from Smith et al [116]).  (a) 
Schematics showing a variety of common quantum dot coatings used for transfer to 
water, including (left to right) mercaptoproprionic acid, polyethylenimine, alkylated 
polycarboxylic acid, lipid-PEG and amphiphilic diblock copolymers.  (b) Transmission 
electron micrographs (TEM) of coated quantum dots in water, counterstained to show 
organic coating layer.  (c) Dynamic light scattering data reveals nanoparticle 
hydrodynamic sizes ranging from ~ 8 nm to over 30 nm.  (d) Nanoparticles can be 
designed with a range of surface charges, depending on the functional groups present 






 A second strategy for the transfer of QDs to aqueous environments involves the 
coating of the hydrophobic nanoparticles with a small amphiphilic polymer.  The overall 
design strategy is to use polymers that are capable of interacting with both the 
hydrophobic surface of the nanoparticle as well as the aqueous environment.  A number 
of polymers have been used for this technique, including low molecular weight polymers 
[53, 108], block copolymers [117, 118], and triblock copolymers [84].  Particles 
transferred using these techniques tend to have higher quantum yields than other 
particles, likely due to the protective layer of the hydrophobic segments of the polymer 
and the original surface ligands.  These particles are also much more stable than ligand 
exchanged QDs, due to the multiple interactions between the polymer and the QD 
surface.  One notable downside to these strategies is a substantial increase in particle 
size, as seen in Figure 2.3.  Retaining the original hydrophobic surface ligands adds an 
additional 1-2 nm to the overall particle size.  In addition, the bulky polymers can 
significantly add to the overall size, resulting in particles that could be as much as 2-3 
times as large as particles prepared using standard ligand exchange methods. 
The coating techniques described above have allowed a number of exciting 
biological studies to be conducted and progress has been made in the use of QDs for 





2.5 QUANTUM DOT-BASED ASSAYS FOR CLINICAL APPLICATIONS 
QDs are of particular interest for diagnostics and molecular imaging because of 
their small size and unique fluorescence properties, as described above.  As a result, 
many groups, including our own, have reported the use of QDs in a variety of 
applications, including live cell imaging and tracking [73, 119-121], single molecule 
tracking [122, 123], cell and tissue staining [53, 54, 81] and in vivo imaging [83-85]. 
 
Solution Assays 
 A number of unique solution based assays have been developed using QDs as 
ultrasensitive imaging agents.  Because of their extremely bright fluorescence (a single 
QD particle can be seen under standard fluorescence microscopy), QDs enable the 
detection of analytes at extremely low concentrations, increasing the sensitivity of many 
standard assays.  In addition, QDs in multiple colors and in varying ratios can be 
embedded into polymer or silica microspheres [43, 47, 86], resulting in an optical 
barcoding system that can be used for distinguishing hundreds or thousands of unique 
analytes.  Another important QD trait exploited to develop sensitive detection assays is 
their large stokes shift and broad excitation profiles, which allows multiple QDs to be 
excited simultaneously using a single, high energy excitation source.  By using 
nanoparticles with two different colors and instrumentation capable of detecting photon 
coincidence, QDs can be used as ultrasensitive probes for the detection of many 
analytes and large particles, as seen in Figure 2.4b [45], and can also be used to detect 
binding events.   This technology has been used to detect virus particles at the single 
virus level and can distinguish variations in viral surface proteins to determine virulence 
in a sensitive manner in real-time [44]. 
 The ability to excite multiple QDs simultaneously as well as their uniform and 
bright fluorescence has also been exploited to perform single molecule detection and 
23 
 
molecular imaging at resolutions much greater than theoretically possible with standard 
optical imaging.  Because the fluorescence intensity profile of a QD can be modeled as a 
Gaussian distribution, algorithms can be developed to pinpoint the location of the particle 
in a very precise manner.  By using QD conjugated probes of different colors (red and 
green) and image processing algorithms, DNA length can be analyzed at the single 
molecule level and at nanometer resolutions (Figure 2.4a), far below the diffraction limit 
associated for traditional light microscopy [42].  This technique can also be used to 
detect the binding of nucleic acid pairs at extremely low levels, providing an assay 
capable of ultrasensitive detection. 
 
Cell and Tissue Staining 
 Cell and tissue staining is another application that has received considerable 
attention for the use of QDs.    As mentioned earlier, organic dyes diminish in 
fluorescence upon exposure to light and can be quenched in seconds to minutes.  This, 
in addition to their lower fluorescence intensity, makes them difficult to use for long term 
tracking of molecules in live cells.  The fluorescence properties of QDs, on the other 
hand, make them ideally suited for this type of application.  Of particular interest for 
these applications are their photostability and the ability to excite multiple QD colors 
simultaneously.  For single molecule tracking, photostability is of utmost importance 
when selected an imaging agent.  QDs have been shown to maintain a stable 
fluorescence intensity under bright excitation for over 30 minutes, enabling them to be 
used for long term molecule tracking [121-123].   
 In addition to interesting molecular studies in cells, tissue staining is proving to be 
an exciting application for QDs [54].  The potential for multiplexing opens the possibility 
of a QD revolution for molecular imaging in cells and pathological analysis of tissues, as 
seen in Figure 2.4d.  Where traditional techniques allow for only a single dye or stain for 
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marker detection, QDs enable the detection of multiple markers simultaneously.  In fact, 
up to five biomarkers have been simultaneously imaged in clinical tissue samples [100], 
with the potential for even higher degrees of multiplexing.  In addition to higher 
brightness and stability, the fluorescence emission spectrum of QDs is well suited for 
use in complex samples.  The QD spectra can be approximated as a normal distribution 
with a narrow peak, unlike dyes, which have broader peaks and tailing effect on the 
lower energy side of the curve.  This makes it easier to subtract background 
autofluorescence from the image and isolate the desired signals.  The optical stability of 
QDs also makes them attractive for this application, where samples are often stored and 







Figure 2.4. Biomedical applications of quantum dots.  Quantum dots have utility in a 
number of diagnostic and ultrasensitive molecular imaging applications in tissue and in 
vivo environments, as well as in solutions.  (a)  Nanometer-scale mapping of single DNA 
chains by microscopy.  By using quantum dot conjugated probes and image processing 
algorithms, DNA length can be analyzed at nanometer resolutions, far below the 
diffraction limit associated for traditional light microscopy (from Agrawal et al [42]).  (b) 
Quantum dots in two colors enable ultrasensitive virus detection at single particle levels 
using photon coincidence (from Agrawal et al [44, 45]).  Quantum dots are also 
extremely useful for multiplexed molecular imaging (c) in vivo (from Gao et al [84]) and 




In Vivo Imaging 
The unique optical properties of QDs have also allowed their use in many 
exciting in vivo applications, including live cell tracking and tumor detection.  QDs with a 
PEG coating have been used in Xenopus embryos to track cells during development and 
were found to be stable, slow to photobleach and nontoxic during the course of the 
experiment [83].  QDs were injected into an individual blastomere during early cleavage 
stages and fluorescence could be tracked to the tadpole stage of development.  This 
exciting new tool for lineage tracking could lead to an enhanced understanding in the 
field of embryology.  QDs have also been employed in the tracking of cancer cells in 
mouse models [120].  Tumor cells were loaded with QDs and then intravenously injected 
into mice.  These labeled cells were tracked as they extravasated into the lung and were 
shown to behave identically to unlabelled cells, providing a powerful method to study 
cancer metastasis.  The ability to track cells in vivo is expected to be an important 
research tool for a broad range of fields, including oncology, embryology, and 
immunology. 
In addition to studying labeled cells, molecular imaging in vivo using QD 
technology has also been reported.  QDs coated with PEG and targeted to prostate-
specific biomarkers have been delivered intravenously into animal models and were 
shown to accumulate in the subcutaneous tumor (Figure 2.4c) [84].  This was the first 
report of simultaneous targeting and imaging of QDs for in vivo applications.  Since that 
work, there have been a number of exciting studies showing the utility of QDs as in vivo 
imaging agents.  In particular, type II QDs (a new class of QDs capable of emission in 
the near infrared) were shown to function well in vivo and could improve the depth 
limitation seen with type I QDs [85].  This limitation significantly hinders the utility of QDs 
emitting in the visible range, where tissue and other components can strongly absorb.  
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Research by our group and others is ongoing to develop new QD probes capable of 
near-infrared emission with quantum yields suitable for use in deep tissue imaging [124]. 
 
2.6 CHALLENGES AND OPPORTUNITIES 
Critical advances in the development and use of QDs and similar nanoparticles 
have made their use in biological and medical applications imminent.  Particularly, 
techniques for coating and water solubilizing high quality nanoparticles have 
substantially contributed to their adoption by biological researchers.  While the progress 
made in this field is monumental, significant challenges remain.  Even nanoparticles 
designed for use in cells, tissues and in vivo exhibit problems such as potential toxicity.  
Usefulness as an in vivo clinical imaging agent, where the potential toxicity of cadmium-
containing QDs is of major concern and the ultimate fate of nanoparticles in the body is 
unclear, remains to be seen for human patients.  Many preliminary studies have shown 
that toxicity issues for QDs in vivo are of some concern [125, 126].  Although this could 
eventually prevent their use in vivo, immunohistological and cellular and tissue staining 
is performed on in vitro or ex vivo clinical samples, where heavy metal toxicity is 
inconsequential.  As a result, the use of multicolor QD probes for tissue staining and 
biomarker detection is likely one of the most important and clinically relevant applications 
in the near term [54, 55, 99, 110]. 
However, a significant hurdle for the use of QDs in this clinical setting is that the 
water soluble probes tend to be ―sticky‖ and often bind nonspecifically to cellular 
membranes, proteins, and extracellular matrix materials.  These nanoparticles also show 
strong binding to components in blood, plasma and serum, significantly limiting their use 
in these samples.  This nonspecific binding problem causes a high fluorescence 
background signal that degrades the signal-to-noise ratio and limits staining specificity 
and detection sensitivity.  It can also lead to false positive staining for biomarkers in cells 
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and tissues.  Recent work has shown that size and surface chemistry play a critical role 
in determining the binding properties of QDs and other nanoparticles.  These discoveries 
present an opportunity for the design of new QD probes that are functional in a range of 
clinical environments. 
As coating strategies continue to develop, new applications for these 
technologies will certainly emerge.  Techniques to minimize the size of the particles as 
well as provide complete protection of the nanoparticle may enable the use of QDs in 
vivo.  It has been shown that small molecules (less than 6 nm) are able to be cleared 
from the body by renal filtration.  Designing nonstick nanoparticles that are stable and 
have a completely protected nanocrystal core could clear the way for the first human 
trials for this technology.  New coatings could also lead to multifunctional probes, which 
can provide imaging capabilities in multiple modalities (such as MRI, CT, PET, etc.) as 
well as deliver a drug payload to the targeted disease tissue.  
Ultimately, these developments will lead to an era of personalized medicine, 
where the diagnosis and treatment of a patient will be done on an individual basis, based 
on the patient’s disease profile.  These technologies will also dramatically reduce the 
time required to diagnosis and treat a patient, rapidly improving patient care. 
 
2.7 CONCLUSIONS 
QDs have been shown to have great potential in the fields of biology and 
medicine, in particular cancer diagnostics.  However, challenges remain before the 
adoption of QDs in clinical applications becomes widespread.  In this work, the 
interaction of polymers and nanoparticle surfaces as well as how surface chemistry 
affects the interaction of nanoparticles and biomolecules will be addressed.  Bright and 
stable nanoparticles are needed to deliver optimal performance for imaging and sensing 
applications.  This work will explore polymer-coatings for QDs and describe the 
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parameters for optimizing nanoparticle stability and optical performance.  The use of 
these low molecular weight polymers in a one-pot nanoparticle synthesis method will 
also open a new avenue for the production of high quality nanoparticles for the clinical 
market.  Nonspecific binding will also be addressed by examining nanoparticle surface 
chemistry and its effects on the interaction of nanoparticles with biological molecules 
such as proteins, nucleic acids and organelle membranes.  The results of these studies 
provide a novel QD suitable for ultrasensitive and multiplexed detection of disease 





SYNTHESIS AND CHARACTERIZATION OF AMPHIPHILIC 
POLYMERS FOR QUANTUM DOT COATING 
 
3.1  ABSTRACT 
Because high quality quantum dots (QDs) are typically synthesized in high 
temperature, oily solvents, the resulting nanocrystals are hydrophobic and unsuitable for 
use in biological environments.  To phase transfer the nanoparticles to water, a variety of 
techniques have been developed, including polymer coating.  In this chapter, we have 
developed and optimized the polymer synthesis and purification techniques to develop 
low molecular weight polymers for use in nanoparticle coating applications.  We have 
also extensively characterized the polymers to determine parameters important for their 
use with QDs and other nanoparticles, including solubility, critical micelle concentration 
(CMC), conjugation percentage and hydrodynamic size in solution.  After successfully 
coating and water solubilizing the QDs, water purification procedures were developed to 
yield highly fluorescent, monodisperse nanoparticles.  The colloidal and optical 
properties of the nanoparticles were then analyzed, particularly absorption and 
fluorescence, quantum yield and hydrodynamic size.  We have also systematically 
altered the polymer synthesis and coating procedure to determine the effects of the 
polymer parameters on the nanoparticle coating process and optimized the stability and 
optical properties for use in biological applications.  It was found that an amphiphilic 
polymer with 40% of the carboxylic acid functional groups modified with a 12 carbon 
aliphatic chain was ideal for QD coating, yielding monodispersed, single particles with 





Advances in polymer science and chemistry have not only increased the 
fundamental understanding of the behavior of molecules on a nanometer level, but also 
led to the development of a number of new and exciting applications for this technology.  
Significant breakthroughs in medicine, materials and energy have been achieved 
because of the progression of polymer technology.  Specifically, polymers have made 
substantial contributions to the development of drug delivery technologies [127-132], 
clinical imaging agents [133-139], organic LEDs or other optoelectronic devices [140, 
141], and drug eluting stents [142, 143],to name just a few applications.  Amphiphilic 
block copolymers (typically with one segment that is hydrophilic and one that is 
hydrophobic) have been extensively studied for use in biomedical applications.  These 
polymers have also been studied on a more fundamental level, examining the complex 
morphologies they can self assemble into (Figure 3.1), to aid in the design of complex, 
polymer-based technologies.  One major driving force for the self assembly of 
amphiphilic polymers into micelles or other particle-like aggregates in polar solvents 
(such as water) is the interaction between the hydrophobic and hydrophilic segments of 
the polymer with the aqueous environment.  Free energy is decreased as hydrophobic 
segments of the polymer are buried in the interior of the nanoparticle and shielded from 
the aqueous surrounding by the hydrophilic segments [144], driving the spontaneous 




Figure 3.1. Self-assembly of block copolymer melts. (a) Illustration of six common 
morphologies taken by block copolymer melts, divided into classical phases (lamellar, 
cylindrical, and spherical) and complex phases (gyroid, perforated-lamellar and double-
diamond) [145].  (b) Theoretical and (c) experimental phase diagrams using polystyrene-
polyisoprene diblock copolymers, where f is the fraction of one block and χN, the Flory-
Huggins parameter, is the mean field approximation of the local interactions between 
polymer segments [145-149].  Experimental measurements match well with the 
theoretically predicted phases. From Matsen et al [145]. 
 
Many groups have taken advantage of this assembly process and used these 
polymers for the encapsulation and soubilization of a number of hydrophobic materials 
for use in aqueous solutions, including drugs and imaging contrast agents.  In particular, 
block copolymers have been extensively used by our group and others for the coating 
and water solubilization of QDs and other hydrophobic nanoparticles [116, 118, 150].  
Using a variety of techniques, polymer micelles can be loaded with as few as one 
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nanoparticle to tens or hundreds of particles, providing a diverse tool for the design of 
single or multimodal imaging agents. 
 
 
Figure 3.2. Illustration showing a graft copolymer with small polymer segments 
randomly ―grafted‖ to a backbone polymer [151].  Hydrophobic and hydrophilic portions 
of the polymer can drive the self-assembly of nanoparticles [152]. From Sakuma et al 
[151]. 
 
Although block copolymers are an excellent tool for the development of micellar 
contrast agents, these particles tend to be large because of the large size of the 
amphiphilic polymers.  Graft copolymers (shown in Figure 3.2) have been studied in less 
detail for these types of applications but are extremely promising.  While block 
copolymers have their segments attached end to end, graft copolymers have a 
―backbone‖ polymer with smaller polymer units randomly ―grafted‖ along its length.  This 
could allow for interesting interactions with the surface of nanoparticles, with the 
backbone wrapping around the particle while the grafts interact with the hydrophobic 
surface ligands present.  In addition, small, ―pseudo‖ graft copolymers could be 
produced that utilize a small polymer backbone with molecules serving as the ―graft‖ 
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segments.  We have hypothesized that these small polymers can effectively coat the 
surface of nanoparticles and allow for an extremely small polymer coating 
To successfully cover the surface of the nanoparticle with a polymer-coating 
suitable for use in biological applications, the polymer must be designed in such a way 
that enables interaction with both the hydrophobic ligands on the surface of the particle 
and the aqueous environment.  Based on these criteria, we hypothesized that an 
amphiphilic polymer with long hydrocarbon chains capable of noncovalent interactions 
with the surface ligands and a hydrophilic backbone to interact with the aqueous 
environment could render the nanoparticles water soluble.  Furthermore, hydrophobic 
and hydrophilic interactions between the nanoparticle surface, the amphiphilic polymer 
and the aqueous solvent are able to drive the self assembly of the polymer on the 
surface of the QDs, completely encapsulating the nanoparticle.  In addition, by varying 
the length of the hydrophobic regions of the polymer, the degree of hydrophobicity and 
the polymer : QD ratio, both the stability and optical properties of the particles can be 
tuned.   
In this chapter, we have developed and optimized the polymer synthesis and 
purification techniques to develop low molecular weight polymers for use in nanoparticle 
coating applications.  We have also extensively characterized the polymers to determine 
parameters important for their use with QDs and other nanoparticles, including solubility, 
critical micelle concentration (CMC), conjugation percentage and hydrodynamic size in 
solution.  After successfully coating and water solubilizing the QDs, water purification 
procedures were developed to yield highly fluorescent, monodisperse particles.  The 
colloidal and optical properties of the nanoparticles were then analyzed, particularly 
absorption and fluorescence, quantum yield and hydrodynamic size.  We have also 
systematically altered the polymer synthesis and coating procedure to determine the 
effects of the polymer parameters on the nanoparticle coating process and optimized the 
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stability and optical properties for use in biological applications.  It was found that an 
amphiphilic polymer with 40% of the carboxylic acid functional groups modified with a 12 
carbon aliphatic chain was ideal for QD coating, yielding monodispersed, single particles 
with quantum yields of 60% or higher. 
 
3.3 METHODS 
Amphiphilic Polymer Synthesis 
 The amphiphilic polymers used in these studies were synthesized using standard 
carbodiimide chemistry.  Poly(acrylic) acid (MW = 1800 Daltons) and a primary 
alkylamine (hexadecylamine, octylamine, decylamine, dodecylamine, tetradecylamine, 
hexadecylamine or octadecylamine) were dissolved in dimethylformamide  (DMF) at a 
molar ratio of 2:5 primary alkylamine to carboxylic acid. Dicyclohexylcarbodiimide (DCC) 
was dissolved in a minimum amount of DMF and added dropwise to the solution in a 
slight molar excess to the primary alkylamine present.  The reaction solution was mixed 
vigorously for 24 hours to give an amphiphilic polymer with 40% of the carboxylic acid 






Figure 3.3. Reaction scheme for an amphiphilic polymer to be used for synthesis and 
coating of nanoparticles for biological applications.  The hydrophobic carbon chains are 
able to intercalate into the hydrophobic surface ligands of the nanoparticle, coating the 




 The polymer solution was cooled in an ice bath to facilitate the precipitation of the 
dicyclohexylurea (DCU) byproduct.  The insoluble DCU was removed using vacuum 
filtration, leaving a transparent, slightly yellow filtrate.  The polymer filtrate was then 
added dropwise to a solution of aqueous sodium hydroxide (pH ~10) under vigorous 
stirring to yield a slightly cloudy aqueous solution.  Vacuum filtration was again used to 
remove any insoluble contaminants (trace DCU, unreacted DCC and alkylamine), 
resulting in a slightly opaque solution.  Under vigorous stirring, hydrochloric acid (HCl) 
was added dropwise to precipitate the polymer product.  This mixture was vacuum 
filtered to collect the precipitated product and washed with deionized (DI) water to 
remove any residual aqueous contaminants.  The purification process was repeated 3 
times by redissolving the product in aqueous sodium hydroxylde (pH ~ 10), filtering to 
remove insoluble contaminants, acidifying to precipitate the polymer and finally collecting 
the precipitate through filtration.  The polymer precipitate was then freeze dried to 




Polymer Conjugation Titration Assay 
 25 mg of purified amphiphilic polymer was transferred to a 125 mL Erlenmeyer 
flask.  The polymer was then dissolved using 50 mL of ethanol (EtOH).  The flask was 
moved to a stir plate and a stir bar was added to completely mix the sample.  2 drops of 
a 2% Phenolphthalein solution (in EtOH) were added to the sample as a color indicator.  
Separately, a 0.05 M solution of aqueous sodium hydroxide (NaOH) was prepared.  The 
polymer sample was titrated with aqueous NaOH under vigorous stirring until the 
solution retained a faint pink color, noting the volume of NaOH used.  Moles of NaOH 
were used to calculate the moles of COOH present and the conjugation percentage of 
the polymer. 
 
Critical Micellar Concentration 
 A 0.6 M solution of pyrene was prepared in acetone.  Polymer solutions ranging 
from 0.5 μg/mL to 1 mg/mL were separately prepared in water (pH ~8).  1 mL aliquots of 
the pyrene/acetone solution were transferred to glass vials and the acetone was 
evaporated overnight under reduced pressure.  1 mL of the polymer concentration series 
were added to the vials and the samples were vortexed.  The samples were then heated 
at 80ºC for 2 hours to equilibrate the partitioning of pyrene into the polymer micelles.  
The vials were then wrapped with foil to prevent light exposure and allowed to cool to 
room temperature overnight.  The samples were analyzed using a spectrofluorometer, 





Polymer Hydrodynamic Size 
 Dynamic Light Scattering (DLS) data, used to determine the polymer aggregates 
hydrodynamic size in water, was obtained on a Brookhaven Instruments 90 Plus Particle 
Analyzer.  Amphiphilic polymers with aliphatic chains from 8 to 18 carbons long were 
dissolved in basic water (pH ~8) at a concentration of 5 mg/mL.  The samples were 
vortexed and sonicated and then filtered through a 0.45 μm filter to remove dust or other 
contaminants present.  500 μL aliquots were then taken and measured using DLS.  
Experiments were carried out for 2 minutes with 3 replicate runs and analyzed using the 
Number Multimodal Size Distribution mode. 
 
Quantum Dot Synthesis 
 Cadmium selenide (CdSe) QDs were synthesized in a noncoordinating solvent 
as reported in previously published procedures.  The nanocrystal cores were purified 
using liquid-liquid extraction with hexane and methanol (MeOH) 3 times.  The purified 
nanoparticles in the hexane layer were then transferred to a centrifuge tube and 
precipitated using an excess of acetone.  The solution was centrifuged at 7000g for 15 
minutes to collect the insoluble QDs.  After resuspending in chloroform (CHCl3), the QDs 
were transferred to a mixture of octadecene (ODE) and octadecylamine (ODA) and 
heated under vacuum to remove any volatile solvents.  An inorganic passivating shell of 
cadmium sulfide (CdS) and zinc sulfide (ZnS) was then grown on the nanocrystals using 
organometallic precursors at ~220ºC, as described in literature.  The crude QD solution 
was then rapidly cooled to room temperature and transferred to glass vials and stored 





Quantum Dot Coating and Transfer to Water 
 
 
Figure 3.4. Quantum dot coating and water purification schematic.  Both hydrophobic 
quantum dots and polymer were dissolved in chloroform (CHCl3) and mixed in a vial.  
The CHCl3 was evaporated under reduced pressure, leaving a polymer/quantum dot 
film.  Basic water (pH 10) was added and the solution was vortexed and sonicated to 
dissolve the coated quantum dots, leaving a slightly opaque solution.  Filtration through 
a 0.2 μm filter resulted in a highly fluorescent, transparent solution. 
 
 An aliquot of crude QDs was diluted into hexane and purified using liquid-liquid 
extraction from hexane and MeOH as described above.  The nanocrystals were then 
precipitated using acetone and centrifuged at 7000 g for 15 minutes to form a QD pellet.  
The pellet was then resuspended in a minimal amount of CHCl3.  Separately, an 
amphiphilic polymer (poly(acrylic acid)-dodecylamine, PAA-DDA) was dissolved In 
CHCl3 at a concentration of 10 mg/mL.  The QD and polymer solutions were mixed in a 
glass vial at a molar ratio of 500:1 polymer to QD (Figure 3.4).  The solution was 
vortexed to ensure complete mixing and the CHCl3 was slowly removed under reduced 
pressure overnight, leaving a thin polymer/QD film in the vial.  Basic water (pH ~10) was 
added to the vial and the solution was vortexed and sonicated in a bath sonicator for 10 
minutes to completely resuspend the polymer coated QDs in water, resulting in a slightly 
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cloudy solution.  The QD solution was then filtered through a 0.2 μm filter to remove any 
insoluble contaminants, yielding a transparent, fluorescent solution. 
 
Water purification of quantum dots 
Water soluble QDs were transferred to a cellulose ester 100 kDa MWCO dialysis 
tube (Spectra/Por) and dialyzed against 2 L of 50 mM Borate Buffer for 7 days, 
exchanging the buffer daily.  The purified solution was then concentrated under reduced 
pressure using a rotavapor at reduced pressure and ~15ºC. 
 
Verification of Polymer Removal 
 Polymer removal from QD samples was determined by TEM.  Purified and 
unpurified QD samples were prepared and filtered to remove any dust contaminants.  5 
μL of the samples were then pipetted onto a carbon TEM grid.  The solvents were slowly 
wicked away with filter paper after 15 minutes and the grids were then counterstained 
with a 1% phosphotungstic acid solution (pH adjusted to 6) for 30 seconds.  The staining 
solution was slowly wicked away and the grids were imaged and compared to determine 
the degree of polymer removal.  FPLC was also used to confirm polymer removal from 
QD samples.  A pure polymer solution was first analyzed to determine it’s elution time.  
Samples of purified and unpurified QD solutions were then analyzed using FPLC and the 
change in intensity of the polymer peak was observed. 
 
Fluorescence microscopy of single quantum dots 
 A 50 nM solution of QDs was prepared for microscopy.  The sample was 
sonicated to disperse any aggregates and filtered to remove contaminants.  1.5 μL of the 
purified QD solution was pipetted onto a glass coverslip.  A second coverslip was placed 
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on top to form a thin film between the coverslips, which was allowed to dry overnight.  
The coverslips were then separated and imaged on a fluorescent microscope at 100x. 
 
Polymer effects on quantum dot fluorescence intensity 
 Amphiphilic polymers with carbon chain lengths from 8 to 16 carbons were 
prepared and used to coat 630 nm QDs at varying QD : polymer ratios.  The QDs were 
transferred to water and purified as described above.  The samples were then diluted to 
200 nM and fluorescence intensity spectra were recorded using a spectrofluorometer.  
Fluorescence intensity was taken as the area under the curve of the fluorescence 
spectrum. 
 
pH Stability of Polymer-Coated Quantum Dots 
 A 100 nM solution of QDs was prepared in DI water and vortexed and sonicated 
for 15 minutes to redisperse any aggregates.  The sample was then filtered using a 0.2 
μm filter to remove any large contaminants.  Separately, a 0.1 M solution of citric acid 
and a 0.2 M solution of sodium phosphate dibasic (Na2HPO4) were prepared in water.  
These solutions were mixed in various ratios to produce buffers ranging from pH 2.5 to 
7.5.  900 μL of the buffers were pipetted into glass vials.  100 μL of the QD sample were 
then transferred to the vials, which were then vortexed briefly to mix the solutions.  
Fluorescence measurements were taken using a spectrofluorometer before and after 
filtering though a 0.2 μm filter and the ratios were then plotted. 
 
Quantum Dot Size Analysis 
 QD size was independently analyzed using 3 separate techniques.  
Counterstained TEM was used to image both the nanocrystal core as well as the 
polymer shell surrounding the core.  These images were analyzed using ImageJ to 
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determine a size distribution for the sample and an average size for the coated particles.  
DLS was used as described above to measure the hydrodynamic diameter of the 
nanoparticles.  QD samples were prepared at 50 nM and filtered using a 0.2 μm filter 
immediately before reading the sample to eliminate dust.  FPLC was also used to 
determine the hydrodynamic size of the QDs.  Briefly, globular protein standards with 
known hydrodynamic diameters were measured and elution time was noted and used to 
develop a standard curve.  QD hydrodynamic size was then analyzed using FPLC 
elution times and the protein standard curve. 
 
3.4 RESULTS AND DISCUSSION 
Because the optical and colloidal properties of quantum dots (QDs) are heavily 
influenced by the protection of the surface and surface ligands of the nanocrysal, we 
hypothesized that these important properties can be optimized by coating with an 
amphiphilic polymer specifically designed for encapsulating the QD and interacting with 
the hydrophobic surface.  In particular, we speculated that the hydrophobic component 
of the polymer was particularly important for an optimally designed amphiphilic polymer.  
This is the portion of the polymer responsible for driving the self assembly of the coating 
through strong noncovalent interactions with the surface of the nanoparticle.  By altering 
the hydrophobic component as well as the ratio of hydrophilic : hydrophobic portions of 
the polymer, we can maximize the noncovalent interactions between the polymer and 
the surface ligands to increase the colloidal stability and further improve the optical 
properties of the nanoparticle. This component also has a significant impact on the free 





Polymer Development and Selection 
In order to develop a polymer-coating suitable for encapsulating and solubilizing 
hydrophobic QDs or other nanoparticles, several important parameters were considered.  
High quality QDs typically have hydrophobic surface ligands with long hydrocarbon 
chains such as hexadecylamine or oleylamine, as shown previously in Figure 2.2.  The 
polymer to be used for nanoparticle coating must have a hydrophobic component 
capable of strong noncovalent interactions with these surface ligands.  An amphiphilic 
polymer containing a number of long hydrocarbon chains was determined to be ideal for 
coating the nanoparticle surface, as they can intercalate into the hydrophobic ligands on 
the surface as the hydrophilic polymer backbone wraps around the nanoparticle.  These 
also provide the added benefit of protecting the surface of the nanocrystal from the 
biological environment.  Fully extended, the surface ligands and polymer-coating provide 
a barrier of approximately 1.5 nm between the aqueous environment and the surface of 
the nanocrystal.  Protection of the nanocrystal surface from water, oxygen or other 
compounds that could react with the nanocrystal and cause surface defects or 
oxidation[116] is extremely important in preserving the excellent optical properties 
exhibited by high quality QDs.  By providing a hydrophobic barrier, similar to the fatty 
acid barrier of a cell membrane, many of these damaging species can be effectively 
blocked from reaching the nanoparticle surface.  The polymer also stabilizes the 
hydrophobic ligands and prevents dissociation from the surface, further preserving the 
outstanding optical properties seen before transfer to water.   
When designing the polymer, the hydrophilic : hydrophobic ratio was another 
important parameter to consider.  Because of their extremely small size, nanoparticles 
have a very small radius of curvature.  This high curvature greatly affects the way 
ligands behave on the surface of the particle and interact with each other.  It was 
necessary to design the polymers with a hydrophobic conjugation percentage low 
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enough to allow the polymer backbone to conform to the curvature of the nanoparticle.  
A 40% conjugation ratio (40% of the original carboxylic acid functional groups 
conjugated to hydrophobic carbon chains) was determined to be acceptable for strong 
interactions with the hydrophobic surface while maintaining good nanoparticle coverage. 
The polymer must also contain a hydrophilic portion capable of interacting with 
the surrounding aqueous environment and rendering the coated nanoparticle water 
soluble.  There are a number of functional groups suitable for nanoparticle stabilization 
and water solubilization, such as carboxylic acids, amines and silica functional groups.  
Carboxylic acids were chosen because of the availability of high quality poly(acrylic acid) 
polymers for use as a polymer backbone and the relatively simple chemistry associated 
with these functional groups.  They have also been shown to provide excellent colloidal 
stability for the nanoparticles [81] and resist particle aggregation through electrostatic 
repulsion.  Based on the above criteria, amphiphilic polymers with a backbone 
containing carboxylic acid functional groups as well as a number of long, hydrophobic 
carbon chains was chosen for further study.   
 
Polymer Synthesis and Purification 
Because poly(acrylic acid), which contains carboxylic acid functional groups, and 
a number of long chain alkylamines are readily available, these were chosen as starting 
materials for the synthesis of amphiphilic polymers for further studies.  Carbodiimide 
chemistry was used to couple a portion of the carboxylic acids to the primary amine of 
primary alkylamine molecules (as shown above in Figure 3.3).  This chemistry is often 
used in peptide synthesis for the formation of amide bonds between the carboxylic acid 
and amine groups of amino acids and in the activation of carboxylic acids towards ester 
formation.  N,N’-dicyclohexylcarbodiimide (DCC) was used as the carbodiimide 
dehydration agent because of its solubility in dimethylformamide and the insolubility of its 
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hydrolysis byproduct, dicyclohexylurea (DCU), for easy purification.  A number of 
parameters for the polymer synthesis were studied to optimize the procedure for a 
variety of conjugation ratios and alkyl chain lengths.  Reaction temperature was found to 
be critical and was optimal at 45ºC, with unpredictable results occurring above 75 ºC.   
Synthesis and purification of a number of amphiphilic polymer variants (varying 
the hydrophobic portion of the polymer) was performed, as described above.  Polymers 
were produced with alkyl chains varying in length from 8 carbons to 18 carbons, while 
keeping the conjugation percentage (percentage of original carboxylic acid functional 
groups modified with an alkylamine) at approximately 40%.  Table 3.1 shows the 
amphiphilic polymers produced as a result of these synthesis procedures. 
 
Table 3.1. Amphiphilic polymer variants used in these studies.  Amphiphilic polymer 
were produced with alkyl chains varying in length from 8 carbons (PAA-OA) to 18 
carbons (PAA-ODA).  Conjugation percentages and molecular weight were calculated by 
titrating the remaining carboxylic acid functional groups of the polymer. 
 
Nomenclature Carbon Chain 
Length 
Conjugation % Molecular 
Weight 
PAA-OA 8 46 3040 
PAA-DA 10 42 3220 
PAA-DDA 12 45 3630 
PAA-TDA 14 42 3800 
PAA-HDA 16 37 3815 
PAA-ODA 18 38 4135 
 
 
An important step in the polymer preparation was the removal of DCU, a 
byproduct of the carbodiimide coupling.  Several strategies were investigated for 
byproduct removal, including centrifugation and filtration.  Our studies have shown that 
maximum byproduct removal was achieved by cooling the reaction solution and 
subsequently vacuum filtering using an 11 micron filter.  The polymer was further purified 
using a precipitation technique to remove excess reactants and byproducts.  Prepared 
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polymers with carboxylic acid functional groups remaining were expected to be soluble 
in slightly basic water because the pKa of a carboxylic acid is approximately 5.  At a pH 
above this value, most of the carboxylic acids will be deprotonated and negatively 
charged, making them very water soluble.  While the product does have a significant 
hydrophobic character, the polymer is able to form small micelles or self-aggregates and 
remains water soluble due to the negative charge of the carboxylate functional groups.  
Aliquots were taken of the polymer and mixed with slightly basic water, yielding a slightly 
opaque solution.  Upon shaking the vial, the solution appeared very soapy and a number 
of bubbles formed, indicating the polymer was dissolved and able to act as a surfactant.  
The polymers solubility in water allowed for an easy purification of the hydrophobic 
impurities remaining in solution (such as DCU byproduct, unreacted DCC, and 
unreacted alkylamine) using simple vacuum filtration.  After filtering, the polymer could 
be collected by a simple precipitation procedure.  By adding acid (dilute HCl) to the 
polymer solution to decrease the pH to below 5, the majority of the carboxylic acid 
groups become protonated (and neutral) again, dramatically reducing their solubility in 
water.  This, in addition to the insolubility of the hydrophobic alkyl chains, forces the 
polymer to precipitate, where it can be easily collected using vacuum filtration and freeze 
dried to remove any remnants of water.  Filtering at this step also allows for the removal 
of any water soluble contaminants or byproducts as well as the DMF solvent used in the 
original synthesis. 
 
Polymer Characterization and Analysis 
In order to measure the success of the reaction and quality of the polymer 
product, several characterization techniques were employed.  First, polymer solubility 
was tested in chloroform.  Unmodified, or only slightly modified, poly(acrylic acid) is not 
soluble in hydrophobic solvents such as chloroform.  Solubility in chloroform was used 
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as an indirect verification of the successful conjugation of alkyl groups to the polymer 
backbone.  For a more quantitative assay of the degree of conjugation as well as the 
molecular weight, titration assays were conducted to measure the remaining carboxylic 
acid functional groups.  A volume of NaOH with known concentration was used to titrate 
the polymer sample.  Phenolphthalein was used as an indicator to determine the moles 
of NaOH needed to completely titrate the carboxylic acids.  Based on these values, and 
the known molecular weights of the original poly(acrylic acid) polymer and alkylamine, 





With the moles of COOH known, solving Equation 3.1 for the moles of alkylamine 
allowed us to estimate the conjugation percentage of the polymer (Conj.%) and the 
molecular weight (MWPOLY) of the polymer using Equations 3.2 and 3.3, respectively. 
 





 The polymers’ critical micellar concentration (CMC) was also measured 
experimentally to analyze the behavior of the polymers in solution.  A pyrene 
fluorescence assay was used to determine the minimum concentration necessary for the 
polymers to aggregate into micelles or micelle-like conformations.  This assay relies on 
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the different fluorescence characteristics of pyrene, a hydrophobic compound, 
depending on the properties of the surrounding medium.  In polar solvents, such as 
water, the fluorescence intensity of the molecule is visible but relatively weak.  However, 
in the presence of a hydrophobic environment, such as the interior of a micelle with a 
hydrophobic core, the fluorescence of the molecule changes and significantly increases, 
as seen in Figure 3.5a.   
At low polymer concentrations (concentrations below the CMC), the polymer 
molecules are free in solution and are unable to encapsulate the fluorophore, subjecting 
the pyrene to the polar environment of water.  As the polymer concentration increases to 
values above the CMC, the polymer molecules are able to capture pyrene in the interior 
of the micelle, providing a hydrophobic environment to increase the fluorescence.  For 
this assay, the fluorescence intensity of the pyrene was plotted as a function of the log of 
the polymer concentration.  CMC was taken as the concentration where fluorescence 
begins to increase, as seen in Figure 3.5b.  For the polymers used in these experiments 
(see Table 3.1), there was a slight difference in the measured CMC values.  Most 
polymers had a CMC of approximately 0.01 mg/mL to 0.1 mg/mL, with PAA-DDA (shown 






Figure 3.5. Polymer critical micelle concentration (CMC).  (a) Pyrene fluorescence 
spectra for increasing polymer concentrations, noting fluorescence intensity at 390 nm 
(dotted line). (b) Pyrene fluorescence intensity at 390 nm as a function of polymer 
concentration.  CMC is noted as the point of inflection where fluorescence intensity 
begins to increase. 
 
 Dynamic light scattering (DLS) was also used to determine the behavior of the 
polymer when dissolved in water.  A sample of the amphiphilic polymer was prepared in 
basic water at a concentration of 5 mg/mL (approximately 2 orders of magnitude higher 
than the CMC) and measured using DLS to observe the formation of polymer 
aggregates.  A representative size histogram is presented in Figure 3.6a, showing a 
relatively narrow size distribution for the purified polymer sample.  Polymers with 
hydrocarbon chain lengths from 8 to 18 carbons (Table 3.1) were measured and the 
mean hydrodynamic diameter was analyzed as a function of carbon length (Figure 3.6b).  
Hydrodynamic diameter was shown to significantly increase as a function of the 
hydrophobic carbon chain length for the size ranges measured in this study.  For 
conjugation percentages held relatively constant, increasing the carbon chain length 
dramatically increases the hydrophobic content of the amphiphilic polymer, relative to 
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the hydrophilic backbone.  With a larger hydrophobic component to shield from the 




Figure 3.6. Hydrodynamic size of polymer aggregates in water, as measured by 
dynamic light scattering (DLS). (a) Size histogram of poly(acrylic acid)-g-dodecylamine 
hydrodynamic diameter in water, showing a narrow size distribution. (b) Polymer 
aggregate hydrodynamic diameter as a function of hydrocarbon chain length.   
 
Phase transfer of Quantum Dots to Aqueous Solution using Amphiphilic Polymers 
With the successful synthesis of a library of amphiphilic polymers, further 
experiments were performed to study and optimize the polymer coating process for 
hydrophobic QDs.  These studies focused on the process of encapsulating the 
hydrophobic QDs with the polymer, as well as purification of the water soluble QDs and 
characterization techniques.  There are a variety of procedures that can be used to drive 
the self assembly of the polymer-coating on the nanoparticles’ surface, including 
emulsion, dialysis and solvent evaporation [84, 108, 110, 112, 117, 150, 153-159].  For 
this work, solvent evaporation proved to be the most effective and simple method for 
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forming high quality, polymer-coated QDs in water.  For the solvent evaporation method 
to be successful, a solvent must be chosen that is able to dissolve both the polymer as 
well as the hydrophobic QDs.  Additionally, the solvent must have a relatively low boiling 
point to allow for evaporation in a timely manner with little to no heating required.  
Chloroform was chosen as the ideal solvent for this procedure because of its low boiling 
point (61ºC) and ability to dissolve both QDs and polymer effectively.  Hydrophobic QDs 
were purified using liquid-liquid extraction and phase transferred into chloroform.  
Separately, amphiphilic polymer was dissolved in chloroform and added to the QD 
solution.  After thorough mixing, the sample was placed under vacuum and the solvent 
was slowly removed.  As the solvent is removed, the hydrophobic alkyl chains are slowly 
driven to intercalate with the surface ligands on the QD, resulting in a polymer-coated 
nanoparticle.  After complete removal of the solvent, basic water is added to deprotonate 
the free carboxylic acids and render the coated QDs soluble in water. 
Based on a geometric model of the amphiphilic polymer and the QD surface 
area, it is estimated that each QD can be optimally covered with approximately 150 
polymer molecules, resulting in a nanoparticle with approximately 2500 carboxylic acid 
groups (each polymer molecule has ~15 COOH groups for the 40% conjugation ratio 
used in these studies).  A molar ratio of 1000 : 1 polymer molecules per QD was used 
for the coating procedure to give a slight excess of polymer in solution (a concentration 
slightly less than one order of magnitude over the optimal ratio) and ensure the surface 
of the QDs was completely covered.  This results in an excess of free polymer that must 
be subsequently removed after dissolving in water to give a pure nanoparticle solution. 
After successfully transferring the coated QDs to water, a number of purification 
techniques were employed and compared to determine the most appropriate for QD 
purification.  Because both the QDs and amphiphilic polymers were independently 
purified prior to coating, purification schemes focused on the removal of free polymer in 
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solution without adversely affecting the optical or colloidal properties of the QDs.  
Ultracentrifugation has been extensively used in the past as a method to separate 
aqueous constituents with different densities.  Studies were conduced to determine the 
efficacy of ultracentrifugation in the separation of polymer coated QDs from free 
polymer.  Our initial results were moderately successful, with QDs forming a pellet on the 
bottom of the centrifuge tube while free polymer remained in the supernatant.  Decanting 
the polymer containing supernatant and resuspending in buffer resulted in a QD solution 
with little to no free polymer.  However, the centrifugation process resulted in moderate 
aggregation of the nanoparticles with a portion of the sample unable to redisperse in 
solution.  In addition, smaller aggregates dispersed in solution were subsequently 
removed during a final filtration through a 0.2 μm filter, resulting in a lower than expected 
yield for the final product.   
To combat these problems, ultracentrifugation was used with a density gradient 
(sucrose gradient solution in centrifuge tube) to separate QDs and polymer without 
aggregating the nanoparticles.  This technique is common for separating protein 
molecules and has been successfully used in a number of applications.  By using a 
sucrose gradient, QDs were prevented from precipitating and were successfully purified 
from the free polymer in solution.  Nevertheless, a number of disadvantages remained 
when using ultracentrifugation.  Foremost, sample throughput was extremely small, 
allowing the preparation of only a small amount of nanoparticles at one time.  In addition, 
use of the sucrose gradient introduced impurities (sucrose) that must be later removed, 
increasing the time required for the purification. 
 In an effort to increase the throughput of QD preparation, dialysis was studied as 
a potential purification method.  A significant advantage of the dialysis method is the 
ability to process large sample sizes in a single batch.  Other advantages include the 
gentle nature of this purification technique (virtually eliminating the aggregation problem 
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seen when using ultracentrifugation) as well as the inexpensive materials and equipment 
needed, in comparison to the centrifugation methods.  Dialysis using a large molecular 
weight cut off (MWCO) of 250 kDa was shown to be successful in removing excess 
polymer but was relatively slow, taking days to weeks to completely remove the free 
polymer.  While considerably longer than ultracentrifugation techniques, sample 
throughput was higher because of the increased sample size and improved product 
recovery.  QD quality was also improved, with virtually no aggregation observed in the 
process.   
Dialysis cut off size was chosen based on results from the polymer 
characterization studies described above, which show free polymer aggregates that are 
10 nm or less in diameter when using PAA-DDA as the coating polymer.  Using this 
MWCO size, significant polymer reduction was seen after a few days, with complete 
removal observed after approximately 10 days.  To improve upon this procedure and 
increase both the maximum sample volume as well as processing time, an ultrafiltration 
procedure was developed.  Ultrafiltration across a small membrane under pressure 
works by the same principle as dialysis and proved to purify the QDs in a much more 
rapid manner, completing the purification in a matter of hours instead of days or weeks.  
Another important advance is the ability to process very large volumes of nanoparticles 
in a single batch, with batch sizes of over 300 mL possible using inexpensive equipment 






Figure 3.7. Removal of excess polymer from water solubilized quantum dots. (a) 
Negatively stained TEM of unpurified quantum dots, showing large excess of free 
polymer in solution.  (b) After purification, little to no free polymer is seen in solution, 
revealing monodisperse quantum dots with a uniform polymer coating. 
 
To analyze the success of the QD purification using dialysis and ultrafiltration, 
TEM was used to visually inspect the samples before and after the process.  Samples 
were taken and negatively stained to visualize the polymer in solution and surrounding 
the QDs.  As seen in Figure 3.7a, free polymer was clearly visible in unpurified samples, 
with aggregates appearing in white and obscuring the view of the nanoparticles.  In 
contrast, TEM images taken after the sample was purified showed virtually no excess 
polymer in solution (Figure 3.7b).  In fact, monodisperse nanoparticles are clearly visible, 
with the polymer shell appearing in white and the nanocrystal core appearing in dark 
black.  Using this technique, we were able to confirm the presence of the polymer shell 
coating, as predicted in our hypothesis.  Based on these results, large quantities of 









Figure 3.8.  Characterization of quantum dot optical properties. (a) Absorption (black) 
and emission (red) spectra of coated quantum dots in water with narrow peak widths, 
indicating a very monodisperse sample.  (b) Fluorescence micrograph showing well 
dispersed quantum dots.  The nanoparticles exhibited characteristic fluorescence 
blinking associated with single particles. 
 
To verify that the optical and colloidal properties of the QDs were maintained 
upon coating, phase transfer into water and purification, samples were taken and 
characterized by several methods.  Absorption and emission spectra were taken before 
and after polymer coating to determine if there was a loss of fluorescence or a change in 
the fluorescence peak.  Polymer encapsulation and phase transfer to water has no 
significant effects on the quantum dot’s fluorescence properties and the particles remain 
very bright with a narrow (<25 nm full width half max) emission peak (Figure 3.8a).  The 
particles are also well dispersed with little to no aggregation, as revealed by 
fluorescence microscopy (Figure 3.8b).  The presence of single particles was further 
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verified by a characteristic blinking behavior for immobilized QDs on a glass slide, 
indicative of well dispersed single particles [160]. 
 
 
Figure 3.9. Confirmation of polymer coating thickness and particle size. (a) Schematic 
showing a geometric model of the quantum dot nanocrystal with surface ligands and 
polymer coating, predicting a shell thickness of approximately 2 nm and an overall 
diameter of 12-13 nm. (b) Transmission electron micrograph (TEM) showing a single 
quantum dot particle in water.  The TEM grid was negatively stained with PTA to provide 
contrast to visualize the polymer (in white).  The polymer shell had a measured 
thickness of approximately 2 nm and the overall particle diameter was approximately 13 
nm. 
 
Transmission electron microscopy (TEM), dynamic light scattering (DLS) and fast 
protein liquid chromatography (FPLC) were also used to independently determine the 
nanoparticle size in solution and study the polymer coating.  TEM was performed on 
purified QD samples, as described above.  After analyzing the image on a particle-by 
particle basis, size histograms were generated to determine the mean diameter of the 
particles, revealing a particle diameter of approximately 12-13 nm.  These values 
strongly agree with the expected values based on a geometric model of the polymer 
coated QD (Figure 3.9a), which predicted a nanoparticle diameter of 13 nm.  Indeed, 
TEM images of single polymer-coated QDs are nearly identical to the predicted structure 
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(Figure 3.9).  TEM further reveals a polymer shell with a thickness of approximately 2-3 
nm, closely matching the predicted values (Figure 3.9b). 
In addition to TEM, DLS and FPLC were used to determine the hydrodynamic 
size of the nanoparticles in solution.  The hydrodynamic size is expected to be slightly 
larger than the size predicted by the model and confirmed using TEM.  This is due to the 
electrical double layer surrounding the charged nanoparticles in water, slightly increasing 
their measured size in solution.  DLS results indicate a nanoparticle size of 
approximately 14 nm, slightly larger than that shown in TEM, as expected.  Further 
studies using FPLC were also conducted to verify the hydrodynamic size measurement 
(Figure 3.10).  Globular protein standards with known hydrodynamic diameters and 
molecular weights were measured in the instrument and elution times were noted and 
used to develop a standard curve (Figure 3.10b).  QD samples in water were then 
analyzed and elution times were noted to determine the hydrodynamic size.  QDs eluted 
at 27.5 min, corresponding to an equivalent size of approximately 550 kDa and 14 nm 
hydrodynamic diameter based on the protein standards, corroborating the data obtained 
using DLS.  Based on the results from these methods, it was determined that the 
polymer-coated QDs have a diameter of approximately 13-14 nm.  TEM also confirmed 
the presence of a polymer coating on the nanoparticles, showing a coating thickness of 





Figure 3.10. Analysis of excess polymer removal and quantum dot hydrodynamic size 
using Fast Protein Liquid Chromatography (FPLC). (a) A significant decrease is seen in 
the polymer elution peak in purified quantum dot samples (~34 min, purple curve) 
compared to samples containing excess polymer (black curve), confirming the removal 
of excess polymer.  (b) Quantum dots eluted at 27.5 min, corresponding to an equivalent 
size of 550 kDa and 14 nm hydrodynamic diameter based on protein standards, 
matching well with dynamic light scattering measurements. 
 
 Colloidal stability of the polymer-coated QDs was analyzed to determine the 
nanoparticles’ utility in a range of environments.  Purified QDs were diluted into 50 mM 
borate buffer (pH ~ 8.5) and stored at 4ºC to determine their stability under long term 
storage.  QDs showed little to no aggregation under these conditions and retained their 
optical and colloidal properties for over 1 year.  Long term storage at -20ºC was also 
studied as a potential preservation method for the prepared QD samples.  QDs in water 
were diluted into glycerol (final solution 50% glycerol) and stored at -20ºC for 6 months.  
Glycerol acts as an antifreeze agent, preventing problems previously seen when storing 
aqueous QD samples at temperatures below the freezing point of water (aggregation, 
decrease in stability).  Samples stored with glycerol performed extremely well and 






Figure 3.11. pH stability analysis of quantum dots.  (a) Fluorescent intensity of filtered 
QDs as a function of pH, normalized using unfiltered samples.  Shaded blue region 
represents the range of pKa values for COOH.  (b) Fluorescence spectra of filtered (red) 
and unfiltered (black) QD samples at pH ~2.5. 
 
 In addition, acid/base stability was analyzed to determine the effects of pH on the 
stability of the nanoparticles (Figure 3.11).  QD samples were diluted into buffers at a 
range of pH values and fluorescence intensities were measured before and after 
filtration through a 0.2 μm filter to determine stability.  Filtering samples allowed for the 
removal of any aggregates formed as a result of the surrounding environment, where 
aggregation would indicate instability of the particles in the solvent.  Fluorescence 
intensity of the samples decreased in a sigmoidal fashion as the pH decreased, 
indicating colloidal instability at low pH, as seen in Figure 3.11a.  This curve matches 
almost identically with published titration curves of common carboxylic acid containing 
molecules, such as acetic acid, which has a pKa of ~4.75 [161].  These results are not 
surprising, as the colloidal stability of the polymer-coated QDs presented in this chapter 
are strongly dependent on the protonation of the carboxylic acid functional groups  on 
the surface of the particles.  As the pH decreases, the carboxylic acid groups become 
protonated and are no longer charged, reducing the electrostatic repulsion necessary to 
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keep the nanoparticles in solution.  At a pH equal to the pKa of the carboxyl groups (pH 
at which 50% of the functional groups are protonated), the charge is no longer strong 
enough to provide colloidal stability and the particles aggregate.  Interestingly, 
fluorescence measurements taken before filtration show the particles remain extremely 
bright (as seen in Figure 3.11b), indicating the polymer coating is able to protect the 
surface of the nanocrystal for a wide range of pH values.  These data suggest that 
simple surface chemistry modifications could be sufficient to designing nanoparticles 
with increased utility in acidic environments.  Indeed, recent work by our group has 
shown that changing the surface chemistry of the nanoparticles can greatly affect the 
stability of particles in a variety of environments [110, 116, 162]. 
 
Effects of Polymer Chain Length on QD Optical Properties 
 Finally, studies were conducted to determine the effect, if any, of the amphiphilic 
polymer hydrocarbon chain length on the optical properties of the QDs.  Amphiphilic 
polymers with carbon chain lengths from 8 to 16 carbons were used to coat QDs, which 
were then phase transferred and purified as described above.  Fluorescence intensity 
measurements were then taken and plotted to determine the effects of polymer 
concentration as well as chain length on the QD fluorescence properties.  As seen in 
Figure 3.12, low polymer concentrations, regardless of carbon chain length, resulted in 
poor fluorescence intensity from the purified nanoparticles.  For these samples, the 
polymer concentration was likely insufficient to completely cover and protect the 
nanoparticles for transfer into water, exposing the QD surface to oxidizing and other 
damaging compounds and resulting in diminished or nonexistent fluorescence.  As the 
polymer concentration increase, fluorescence intensity plateaus as expected, when the 
QD surface is sufficiently covered in polymer.  Another interesting finding is the 
dependence on carbon chain length.  The fluorescence intensity of the samples 
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increases as the carbon chain increases, to a value of 12 carbons (corresponding to 
PAA-DDA).  However, further increasing the hydrocarbon chain length results in a 
significant decrease in the QD fluorescent intensity.  It is hypothesized that the increased 
length of the long hydrocarbon chains significantly hinders the intercalation of the 
polymer into the surface ligands present on the nanoparticle.  This results in an 
incomplete coverage of the particle, reducing the colloidal stability of the particles and 
leaving unprotected pockets available for attack by reactive molecules.  
 
 
Figure 3.12. Quantum dot fluorescence intensity as a function of polymer concentration 
and carbon chain length.  Using low polymer concentrations resulted in insufficient 
coverage and protection of the nanoparticles and decreased fluorescence intensity, 
which plateaus with higher polymer concentrations.  Polymers with 12 carbon 
hydrophobic chains were shown to be optimal for maximum fluorescence intensity. 
 
3.5 CONCLUSIONS 
In this chapter, we have described the design, development and synthesis of 
amphiphilic polymers suitable for coating hydrophobic nanoparticles and transferring 
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them to water.  Our studies have also shown that QDs perform very well when phase 
transferred to aqueous solutions using amphiphilic polymers.  Nanoparticles coated with 
a thin polymer shell show no shifting in emission color and almost no loss of 
fluorescence intensity compared to QDs that are solubilized using other strategies, such 
as ligand exchange with small hydrophilic molecules.  The polymer-coated particles are 
also very stable in solution, showing no aggregation after more than 12 months.  This is 
likely due to polymer stabilization of the surface ligands and prevention of ligand 
dissociation, which can lead to aggregation.  Of particular interest, QDs with a polymer 
shell provide an additional benefit of protecting the surface of the particle from the 
surrounding aqueous environment, where water, oxygen or other compounds could 
react and cause surface defects or oxidation [116].  This is accomplished by the 
hydrophobic layer from the surface ligands and hydrophobic portions of the coating 
polymer.  Although this coating provides considerable protection of the excellent 
properties of the QDs, a small group of molecules are able to reach the surface and 
cause some damage to the QDs [162, 163].  Research is ongoing to enhance the 





AMPHIPHILIC MULTIDENTATE POLYMERS FOR ONE-POT 
SYNTHESIS, ENCAPSULATION AND SOLUBILIZATION OF 
QUANTUM DOTS 
4.1  ABSTRACT 
Quantum dot (QD) nanoparticles are expected to have many applications in a 
broad range of fields, from medicine to digital displays and energy.  While significant 
progress has been made in the production of high quality nanocrystals, compromises 
are generally made in scale, ease of production or quality.  For the successful use of 
these particles in a number of applications, high quality particles must be produced in a 
simple, scalable process.  In this chapter, we show the development of multidentate 
precursor ligands for high quality nanocrystal production and the use of these ligands for 
a one-pot synthesis procedure for QDs.  By using these polymer precursor ligands, the 
growth kinetics of the synthesis can be tightly controlled, allowing the production of very 
uniform particles as well as very small nanocrystals.  The QDs produced using this 
method are also resistant to Ostwald ripening, making the particles extremely stable.  By 
using high boiling point, hydrophilic solvents (such as PEG) in addition to excess 
amphiphilic polymer, we are able produce water soluble QDs in a true one-pot synthesis 
procedure.  In addition, this synthetic procedure allows for in-situ growth of an inorganic 
passivating shell on the QD core, opening the possibility of bandgap engineering and 






Semiconductor quantum dots (QDs) are currently under intensive research for a 
broad range of applications, ranging from molecular and cellular imaging to solar energy 
conversion [53, 77, 78, 80-85].  The development of high quality synthesis procedures is 
particularly important for the incorporation of nanoparticles into a number of these 
applications.  Significant advances have been made in the colloidal synthesis of highly 
crystalline and monodispersed QDs, especially with the use of organometallic and 
chelated cadmium precursors [103, 104], noncoordinating solvents [105], and inorganic 
passivating shells [106, 107].  However, these synthesis procedures are generally time 
consuming with many steps and the resulting nanocrystals are typically hydrophobic and 
must be rendered water soluble post-synthesis through a variety of encapsulation or 
ligand exchange processes for many important applications [84, 108, 109].   
Aqueous synthetic procedures have been used as alternative approaches to 
prepare QDs suitable for use in biological environments.  These methods typically use 
small thiol-containing molecules or polymers with carboxylic acid functional groups as 
stabilizing agents and surface ligands [164-170] and water soluble precursors for 
cadmium and tellurium.  While aqueous synthetic techniques are commonly used 
because of their simplicity and relative safety, this approach generally yields suboptimal 
QDs with lower fluorescence brightness and a higher size polydispersity than can be 
achieved with the high-temperature organic procedures.  Moreover, the colloidal and 
optical stability of QDs prepared using aqueous procedures are typically lower than QDs 
prepared using other procedures. 
High quality synthesis of QDs and other nanoparticles often involve the use 
hydrophobic carboxylate ligands to coordinate the precursor atoms in solution and bind 
the nanoparticle surface for stabilization during the synthesis procedure [104].  It was 
observed that the low molecular weight amphiphilic polymers used previously for the 
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coating of hydrophobic QDs (described in Chapter 3) were similar in structure to the 
hydrophobic carboxylate ligands used during QD synthesis to coordinate the precursor 
atoms in solution and bind the nanoparticle surface for colloidal stability (Figure 4.1).  
Based on this observation, it was hypothesized that the amphiphilic polymers could 
serve as multidentate ligands in the synthesis of high quality nanoparticles, allowing for a 
high degree of size control and increased nanoparticle stability.  Furthermore, by using 
an excess of polymer during the synthesis procedure and a noncoordinating amphiphilic 
solvent that is miscible with water, free polymer molecules could encapsulate the 




Figure 4.1. Cadmium Oleate, a common cadmium precursor for quantum dot synthesis, 
is formed by reacting cadmium oxide with oleic acid at elevated temperatures.  The 
amphiphilic polymers discussed previously provide both the carboxylic acid functional 
groups used for coordination with the cadmium atom and aliphatic carbon chains, 
making them useful in precursor formation. 
 
 
Here, we show an ―all-in-one‖ strategy for the simultaneous synthesis, 
encapsulation, and solubilization of high-quality QDs. This one-pot method is based on 
the use of amphiphilic multidentate ligands and noncoordinating solvents such as low-
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molecular weight polyethylene glycol (PEG) (MW = 350 Daltons).  The multidentate 
polymer ligands contain aliphatic chains and carboxylic acid functional groups, and were 
found to act as both a cadmium precursor ligand and a nanoparticle surface stabilizer, 
leading to improved control of chemical reaction kinetics, increased resistance to 
Ostwald ripening and increased colloidal stability.  In addition, by performing the 
synthesis in noncoordinating amphiphilic solvents such as PEG, nanoparticles can be 
immediately phase transferred to water, making this a true one-pot procedure.  When 
exposed to water, excess polymer molecules spontaneously encapsulate and solubilize 
the QDs without any additional materials or steps. Furthermore, this synthetic procedure 
allows for in-situ growth of an inorganic passivating shell on the nanocrystal core, 
enabling one-pot synthesis of both type-I and type-II core-shell QDs [172].  
In this chapter, we have developed multidentate polymer precursors and 
determined their effectiveness in the synthesis of QDs.  In addition, we have studied the 
effects of using the multidentate polymer ligands on the reaction kinetics of QD synthesis 
and nanoparticle properties in comparison to traditional synthetic procedures for QDs in 
organic solvents.  We have also examined the effects of the polymer and solvent in 
successfully transferring the nanoparticles to water.  Additional studies were conducted 
to optimize the growth of an inorganic passivating shell on the nanoparticles in situ, to 







 The amphiphilic polymer PAA-DDA (~ 3500 Daltons) was synthesized using 
standard carbodiimide chemistry, as described above.  Briefly, 518 mg of poly(acrylic) 
acid (MW = 1800 Daltons) and 533 mg of dodecylamine (2:5 ratio of alkylamine:COOH) 
were dissolved in 20 mL DMF.  609 mg of dicyclohexylcarbodiimide dissolved in a 
minimum amount of DMF was added dropwise and the solution was mixed vigorously for 
24 hours to give an amphiphilic polymer with 40% of the carboxylic acid functional 
groups modified with a 12-carbon aliphatic chain.  The polymer was purified using the 
water precipitation method previously described. 
 
Synthesis of Cadmium Telluride (CdTe) Cores Using Mulitdentate Polymer 
Ligands 
 Approximately 170 mg (0.6 mmol COOH groups) of the amphiphlic polymer (~ 
3500 MW, described above) was dissolved in 0.5 mL ODE at 100°C under vacuum to 
remove volatile compounds and dissolved gases.  12.84 mg (0.1 mmol) CdO was added 
and the solution was heated to 200°C under Argon to form the carboxylate precursor.  
3.5 mL ODE were added to dilute the solution and the remaining steps were carried out 
under an inert environment using standard airless procedures.  The solution was heated 
to 300°C and a Tellurium precursor solution (0.05 mmol Te dissolved in 25 μL 
tributylphosphine and 1 mL ODE at 200°C) was quickly injected under vigorous stirring 
to initiate nanocrystal growth.  Reaction progress was monitored by taking 100 μL 
aliquots at various time points using standard airless techniques and rapidly cooling to 





No-Injection Synthesis of CdTe QDs 
 Both Cd and Te precursor solutions were prepared, as described above.  The Te 
precursor solution was then added to the Cd solution at low temperatures (~150ºC).  The 
reaction mixture was purged under vacuum to remove oxygen and the remaining steps 
were conducted under an Argon environment.  The reaction mixture was then slowly 
heated to 240ºC to initiate nucleation and facilitate nanocrystal growth.  Reaction 
progress was monitored by taking 100 μL aliquots at various time points using standard 
airless techniques and rapidly cooling to room temperature to halt the nanocrystal 
growth. 
 
Reaction kinetics of CdTe core synthesis 
 QD synthesis using multidentate polymer ligands was performed as described 
above.  Aliquots were taken using standard air-free techniques at various time points 
and rapidly cooled in cold solvent to halt the reaction.  Fluorescence emission and 
absorption spectra were obtained using a spectrofluorometer and Uv-Vis absorption 
spectrometer, respectively.  Reaction kinetics were compared to QDs prepared under 
identical conditions, using traditional monovalent ligands. 
 
One-pot synthesis of water soluble quantum dots using hydrophilic solvents 
 Approximately 170 mg (0.6 mmol COOH groups) of the amphiphlic polymer (~ 
3500 MW, described above) were dissolved in 1.5 mL PEG (350 MW) at 100°C under 
vacuum to remove water and dissolved gases.  12.84 mg (0.1 mmol) CdO were added 
and the solution was heated to 200°C under Argon to form the carboxylate precursor.  
2.8 mL PEG were added to dilute the solution and the remaining steps were carried out 
under an inert environment using standard airless procedures.  The solution was then 
heated to 300°C and a Tellurium precursor solution (0.05 mmol Te dissolved in 25 μL 
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tributylphosphine and 1 mL PEG at 200°C) was quickly injected under vigorous stirring 
to initiate nanocrystal growth.  Reaction progress was monitored by taking 250 μL 
aliquots at various time points using standard airless techniques and rapidly cooling to 
room temperature to halt the nanocrystal growth. 
 
Quantum Dot Size Analysis 
 TEM was used to image the nanocrystal core and determine the mean size and 
size distribution of the prepared QDs.  Briefly, QDs prepared using the one-pot method 
in PEG were precipitated using centrifugation and resuspended in CHCl3 at a 
concentration of ~100 nM.  The sample was sonicated to disperse any loose aggregates 
and a 1.5 μL aliquot was pipetted onto a carbon TEM grid and allowed to dry.  The 
sample was imaged using TEM and these images were analyzed using ImageJ to 
determine a size distribution for the sample and an average size for QDs.   
 
In-situ capping of CdTe core QDs with CdSe 
 CdTe cores were synthesized in PEG with multidentate polymer ligands as 
described above.  The reaction was allowed to proceed to completion to deplete the Te 
precursor in solution (monitored by observing shift in fluorescence spectra).  The 
solution was then cooled to 180-200°C for the CdSe capping procedure.  A 0.1 M 
selenium precursor solution was prepared using standard airless technique.  Briefly, 
78.96 mg Se was dissolved in 250 μL trubutylphosphine and 9.75 mL PEG at 50°C and 
then cooled to room temperature.  2 mL of the Se precursor solution was added 
dropwise over the course of an hour while the core solution was vigorously stirred and 





4.4 RESULTS AND DISCUSSION 
Multidentate Precursor Preparation 
Based on the successful coating of hydrophobic QDs with low molecular weight, 
amphiphilic polymers (Chapter 3), it was hypothesized that these polymers might enable 
a one-pot method for high quality QD synthesis and immediate phase transfer to water.  
These polymers contain both carboxylic acid functional groups (necessary for 
coordination with cadmium ions) and long hydrophobic carbon chains that bind and 
protect the nanocrystal surface and provide colloidal stability in organic solvents, which 
are necessary to act as a cadmium coordinating ligand.  From these observations, a 
series of experiments were developed to test the feasibility of preparing multidentate 
polymer ligands for use in QD synthesis procedures.  Schematic structures of the 
proposed multidentate cadmium ligands and the self-encapsulated, water soluble QDs 
are shown in Figure 4.2.   
An important precursor in the proposed synthesis procedure is the cluster of 
chelated cadmium ions (Figure 4.2a), formed by dissolving the amphiphilic polymer and 
cadmium oxide or cadmium acetate in a noncoordinating solvent such as octadecene 
(ODE) at elevated temperatures.  Cadmium ions are chelated between neighboring 
carboxylic acid functional groups on the polymer, providing a polymer precursor 
containing multiple cadmium ions (cadmium polyate).  The reactivity of this precursor 
plays a key role in controlling both the nucleation and growth kinetics of the 
nanoparticles and can be tuned by altering the structure of the polymer.  By increasing 
the length of the polymer backbone and the density of hydrophobic side chains, a 
dramatic steric hindrance effect was observed, resulting in homogeneous nucleation and 
growth, whereas the use of traditional monovalent ligands under similar conditions leads 
to uncontrollable and heterogeneous results.  Based on our initial studies, we have 
found that a 40 percent graft percentage (40% of the carboxylic acid groups are modified 
71 
 
with hydrophobic aliphatic chains) of a 12 carbon hydrocarbon group is optimal for 
controlled nanoparticle growth and potential transfer of the QDs to water and other 
solvents.  For the remainder of this work, PAA-DDA was used for the multidentate 




Figure 4.2. (A) Schematic structure of the amphiphilic multidentate ligand with multiple 
chelated cadmium ions. (B) Diagram showing multidentate ligand binding to the quantum 
dot surface.  The resulting nanocrystals are spontaneously encapsulated and solubilized 
by a second layer of the same multidentate polymer upon exposure to water. 
 
QD Synthesis and Reaction Kinetics 
After preparing the multidentate polymer precursor, experiments were conducted 
to determine the optimal reaction parameters for QD synthesis and analyze the 
nucleation and growth kinetics observed when using polymer ligands.  QDs were 
prepared under conditions identical to the monovalent synthesis procedure, replacing 
cadmium oleate precursors with the multidentate cadmium precurors described above.  
Upon anlaysis of the growth kinetics of polymer-prepared QDs, a number of interesting 
properties were observed.  By increasing the concentration of polymer in the reaction 
mixture (effectively increasing the COOH:Cd ratio), a decrease in the nucleation and 
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growth kinetics was observed (Figure 4.3a).  This was unexpected, as an analysis of the 
reaction kinetics seen in monovalent synthesis techniques [105] reveals the opposite 
effect.   
 
 
Figure 4.3.  Unique growth properties of polymer synthesis procedure. (a) Fluorescence 
wavelength and full width half max (FWHM) as a function of time and polymer 
concentration, showing a decrease in nanoparticle growth rate with increasing polymer 
precursor concentration (opposite effect seen with monovalent precursors).  (b) 
Preparing a reaction flask containing both precursors and then rapidly increasing 
temperature results in nucleation of nanoparticles without the need of an injection step, 
which is necessary for synthesis using monovalent precursors. 
 
It is hypothesized that this significant difference is the result of steric hindrance 
from the multidentate polymer precursors.  Using monovalent ligands for cadmium 
precursors, steric hindrance plays no significant role in the kinetics of nanoparticle 
nucleation or growth because the precursor is always composed of two oleic acid 
molecules coordinating a single cadmium ion, regardless of the oleic acid concentration.  
By increasing the concentration of oleic acid, only the reactivity of the cadmium chelate 
is affected by increasing the concentration of carboxylic acids present in the solution.  
Conversely, by altering the concentration of the multidentate polymer when preparing 
the cadmium precursor, the structure of the cadmium polyate is significantly altered.  At 
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low polymer concentrations, the structure most likely obtained is one in which multiple 
cadmium ions are coordinated by a single polymer, as shown in the schematic 
representation in Figure 4.2a.  However, as the concentration of the polymer increases, 
the number of cadmium ions per polymer decreases and the probability that a cadmium 
ion may be coordinated by carboxylic acid groups from separate polymers is higher.  
This phenomena essentially allows the tuning of the effective molecular weight of the 
precurosr by changing the polymer : cadmium ratio.  Because of this increase in 
molecular weight, steric hindrance plays a significant role in the reaction kinetics.  With 
increased steric hindrance, both nucleation and nanocrystal growth kinetics are retarded 
despite an increase in the concentration of carboxylic acids in solution, enabling an 
interesting method for controlling the nanoparticle growth. 
Another interesting property of the polymer procedure for QD synthesis is the 
ability to perform ―no-injection‖ nucleation of nanocrystals.  For typical synthetic 
procedures using monovalent precursors, a solution of an anion chalcogen precursor 
(sulfur, selenium, tellurium) is prepared separately and then rapidly injected into the hot 
cadmium precursor solution to initiate nanoparticle nucleation and subsequent growth.  
This presents a problem for the scale up of these reaction procedures, as it is 
increasingly difficult to rapidly inject larger volumes of chalcogen precursor and the time 
needed for the solution to mix completely increases.  This can lead to a more 
polydisperse product, lowering the quality of the resulting nanoparticles.  By using the 
cadmium polyate precursor, the chalcogen precursor can be separately prepared and 
added at low temperatures and allowed to mix completely.  After a homogenous solution 
is obtained, the temperature can then be increased to induce nucleation of the 
nanoparticles, as seen in Figure 4.3b.  This development provides a potential path 
towards large scale production of QD nanoparticles that would be needed for a number 






Figure 4.4. Reaction kinetics of CdTe core synthesis. (A) Temporal evolution of the 
absorption spectra for CdTe cores synthesized using the amphiphilic multidentate ligand 
procedure. (B) Reaction kinetics of the multidentate ligands compared to traditional 
monodentate ligands. 
 
Next, the overall growth rate of the nanoparticles synthesized using multidentate 
ligands was directly compared to procedures using monodentate oleic acid precursors.  
CdTe core synthesis reactions were carried out under identical conditions, with a COOH 
: cadmium ratio of 6:1 for both procedures (Figure 4.4).  The polymer synthesis 
procedure resulted in a very slow nanocrystal growth, as evidenced by the absorption 
spectra taken over time (Figure 4.4a).  In fact, depending on the polymer concentration, 
the nanocrystals were still growing after more than 10 minutes at 270ºC.  In contrast, 
QDs synthesized with oleic acid precursors grew very rapidly and were much quicker to 
plateau (Figure 4,4b).  This again is attributed to the increased steric hindrance of the 
polymer ligands as well as multivalency.  As the nanoparticles are formed and grow, it is 
hypothesized that the polymer is able bind the surface of the QD in a multivalent fashion 
(see diagram in Figure 4.2b).  Assuming the kon and koff rates are similar for carboxylic 
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acids in oleic acid and the amphiphilic polymer when binding to the nanoparticle surface, 
multivalent binding will result in an effective kd (dissociation constant) that is lower than 
for monovalent binding (meaning an effectively higher binding affinity).  Because of this 
higher affinity, the deposition of cadmium and chalcogen monomers on the surface of 
QDs protected by polymer ligands is expected to be significantly slowed, which is 
consistent with the data.  In addition, a single amphiphilic polymer is more than 12 times 
the size of an oleic acid molecule (~3500 Da vs. 282.5 Da), which may also slow the 
kinetics down through steric effects. 
 
One-pot synthesis 
 After successfully synthesizing QDs using the multidentate polymer ligands, a 
sample of the QDs in the crude reaction mixture (containing octadecene, TOP, excess 
polymer) was transferred to water to determine if the nanoparticles could be immediately 
phase transferred through a spontaneous coating with excess polymer (Figure 4.5).  
After vigorously mixing, a two phase system was obtained, with ODE and QDs in the 
hydrophobic layer and water and impurities in the hydrophilic layer, as seen in Figure 
4.5b, right.  It was determined that the presence of the ODE solvent hindered the 
transfer of these nanoparticles to water, regardless of the concentration of excess 
polymer in solution.  To combat this problem, it was necessary to select a different 
solvent that was capable of acting as a noncoordinating solvent for the QD synthesis 
and an ―adjuvant‖ for immediately transferring the prepared particles to water.  Low 
molecular weight PEG was identified as a potential reaction solvent because of it’s 
similarity to the structure of ODE (Figure 4.5a), its miscibility with a number of solvents 
(especially water) and its relatively high boiling point, important for producing high quality 
particles.  PEG provides not only an inert and noncoordinating environment for quantum 
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dot synthesis at high temperatures, but also acts as an ―adjuvant‖ to facilitate 
nanoparticle dispersion in a variety of solvents.   
 
  
Figure 4.5. Phase transfer of polymer synthesized quantum dots to water. (a) Typical 
high temperature synthesis procedures use high boiling point, oily solvents such as 
octadecene (ODE), which is immiscible in water, making transfer of QDs to water 
difficult.  Polyethylene glycol (PEG) was identified as a potential substitute because of its 
high boiling point and excellent water miscibility. (b) Phase transfer of quantum dots to 
water using PEG (left) and ODE (right).  Hydrophobic solvents such as ODE result in 2 
solvent phases, making water transfer difficult. 
 
After successfully synthesizing QDs using PEG as a replacement for ODE, an 
aliquot of the crude reaction mixture was transferred to water and thoroughly mixed.  As 
seen in Figure 4.5b, left, the crude solution was completely miscible with water and the 
prepared QDs remained colloidally stable and fluorescent.  By optimizing the balance 
between the hydrophobic and hydrophilic portions of the polymer, the resulting 
nanocrystals are solubilized by a second layer of excess polymer when the reaction 
mixture is exposed to water or buffer (Figure 4.2b).  However, if the hydrophobic grafting 
percentage is too high, the number of surface carboxylic acid functional groups becomes 
too low for water solubilization.   
Indeed, the QDs produced using this method show ―amphibious‖ behaviors and 
were soluble in a wide range of hydrophilic and hydrophobic solvents including water, 
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DMF, acetone, and chloroform.  It was hypothesized that the nanoparticles were coated 
with excess polymer to transfer them to polar solvents, such as water.  Solubility in 
hydrophobic solvents is likely due to the hydrocarbon chains from the polymer ligands 
being exposed to the solvent.  To test this hypothesis, an aliquot of crude QDs in PEG 
was taken and transferred to two separate centrifuge tubes.  One tube was immediately 
phase transferred to water, yielding water soluble fluorescent nanoparticles, as 
expected.  The second sample was cooled and centrifuged to precipitate the QDs.  After 
removing the supernatant (along with the excess polymer), buffer was added to water 
solubilize the QDs.  Samples prepared in this manner resulted in an aggregated sample 
with QDs insoluble in water, verifying the need for excess polymer in solution.  However, 
the QD pellets were soluble in a number of nonpolar solvents, such as chloroform, 
consistent with our hypothesis. 
As described above, the improved control in nanoparticle growth kinetics seen 
with the polymer precursor ligands allowed for a more precise tuning of the nanoparticle 
size and fluorescence emission wavelength across a wide range (Figure 4.6a).  In fact, 
QD fluorescence emission could be consistently controlled within as little as 2 nm.  The 
use of these amphiphilic polymer precursors also provides a new route to ultrasmall 
QDs; for example, small CdTe cores emitting in the green range (515 – 525 nm, as small 
as 1.5 nm) can be produced with narrow size distributions, allowing for a large 
fluorescence dynamic range from the green to the far red wavelengths (Figure 4.6a).  It 
is worth noting that ultrasmall QDs are often difficult to synthesize with traditional 
monovalent precursors because of problems with kinetic control of small particles.  The 
QDs coated with the amphiphilic ligands were also strongly resistant to Ostwald ripening, 
likely due to the multidentate interactions described previously.  Each polymer has 
approximately 15 carboxylic acid functional groups that are capable of coordinating with 
surface atoms of the QD.  By increasing the overall binding affinity through multivalent 
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interactions and providing steric hindrance, the polymer coating can better stabilize the 
nanoparticles and reduce ripening.  However, some ripening can occur at increased 
temperatures after substantial periods of time, as shown by the dark red curve obtained 
after 1 hour at 280°C (Figure 4.6b, slight tailing).  Overall, transmission electron 
microscopy reveals uniform, nearly spherical particles without clustering or aggregation 
when using the polymer synthesis procedure in PEG (Figure 4.6c), confirming the 




Figure 4.6. Fluorescence emission and electron microscopy structural properties of 
CdTe core quantum dots prepared by using multidentate polymer ligands in a one-pot 
procedure. (A) Series of monodispersed CdTe quantum dots, showing bright 
fluorescence from green to red (515 to 655 nm) upon illumination with a UV lamp. (B) 
Normalized band-edge fluorescence emission spectra of CdTe quantum dots with 35-50 
nm full width at half-maximum (FWHM) (QY ~ 30%). (C) Transmission electron 
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micrograph of CdTe cores (emission = 655 nm) showing uniform, nearly spherical 
particles. 
 
 Size monodispersity for QDs prepared using multidentate polymer precursors in 
PEG is comparable to nanoparticles produced using traditional monovalent ligands in 
high temperature organic solvents.  TEM was performed on samples and analyzed to 
develop a size histogram for the QDs (Figure 4.7).  In a characteristic sample, prepared 
nanocrystals had a mean diameter of 4.2 nm with a standard deviation of approximately 
10%.   
 
 
Figure 4.7. Size histogram of CdTe cores.  CdTe core QDs were synthesized using the 
polymer procedure. A transmission electron micrograph was taken and analyzed to 
determine size distribution of the particles (mean diameter = 4.2 nm, standard deviation 
~ 10%). 
 
In-Situ Capping with an Inorganic Passivating Shell 
Because QD cores show a propensity to oxidize in water, decreasing their 
fluorescence intensity and eventually degrading the nanocrystal, we have developed an 
in-situ procedure for capping them with an inorganic passivating shell.  Inorganic shells 
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have the added benefit of increasing the fluorescence quantum yield as well as opening 
the possibility of bandgap engineering[124, 172] through the selection of an appropriate 
shell material.  Through bandgap engineering, we can design high quality QDs with 
extended emission ranges, from the ultraviolet into the near infrared.  In this procedure, 
an excess of multidentate cadmium precursor was used to start the core QD synthesis 
(the mole ratio of cadmium to tellurium is typically 2:1 or higher), and the reaction was 
allowed to proceed until the limiting species (tellurium) was depleted.  After completely 
removing the tellerium species, an excess of the cadmium precursor is available for 
incorporation into an inorganic passivating shell with a different chalcogen.  CdSe was 
used as a model shell material for CdTe cores because the band offsets are such that 
CdTe/CdSe is a type-II core-shell QD with light emission in the near-infrared range.[172]  
This provides a dramatic shift in the emission spectra as well as significant changes in 
the shape of the absorption spectra, allowing for definitive evidence that the shell growth 
was successful. 
Fluorescence emission spectra (Figure 4.8a) showed significant red-shifting of 
the original quantum dot core emission peak, from 650 nm to 810 nm, as the CdSe 
inorganic passivating shell was grown on the nanocrystal surface (quantum yields were 
consistent with those reported in literature [172]). Considerable broadening of the 
emission peak was also observed with the shell growth, consistent with the behavior of 
type-II QDs. Monitoring of the nanoparticle absorbance spectra also confirms shell 
growth and transition to type-II behavior (Figure 4.8b).  For example, the distinct exciton 
peak seen in the CdTe cores (red curve) was gradually red-shifted and eventually 
disappeared during shell deposition. This was expected as the CdTe/CdSe quantum 






Figure 4.8. Type-II core-shell CdTe/CdSe quantum dots synthesized in a one-pot 
method. (A) Normalized fluorescence emission spectra showing the transition from CdTe 
cores (red curve) to CdTe/CdSe core-shell quantum dots emitting in the near-infrared 
(black curve). (B) Optical absorbance showing the red-shifting and eventual loss of the 




In summary, we have reported a new, one-pot procedure for preparing high-
quality QDs based on the use of amphiphilic multidentate ligands and short polyethylene 
glycols at high temperatures. The novel features associated with the use of polymeric 
precursors are better control of the nanocrystals growth kinetics, resistance to Ostwald 
ripening, and synthesis of ultrasmall dots with blue-shifted emission spectra.  This 
synthetic procedure also allows for in-situ growth of an inorganic passivating shell 
(CdSe) on the QD core, opening the possibility of bandgap engineering for these 
nanoparticles and providing a large dynamic range for QD emission from the visible to 
the near infrared.  Finally, by using amphiphilic PEG as a noncoordinating solvent for the 
synthesis, QDs can be immediately phase transferred to water, with excess polymer 




AMPHIPHILIC MULTIDENTATE POLYMERS FOR ONE-POT 
SYNTHESIS OF SERS ACTIVE GOLD NANOPARTICLES 
 
5.1  ABSTRACT 
The interesting electronic and optical properties of gold colloids have led to an 
explosion of interest in these nanoparticles and a rush to use them in many exciting 
applications, including biomedical imaging and therapeutics.  In particular, the use of 
gold nanoparticles (AuNPs) as SERS active tags has shown tremendous potential for 
near-term clinical adoption.  Recent work by our group and others has shown that 
biocompatible coatings are necessary for the development of functional probes suitable 
for use in biological environments.  However, synthetic procedures for the production of 
high-quality particles must be scaled up to quantities needed for use in vivo.  In this 
chapter, we show the development of a novel, one-pot synthetic procedure for the 
production of SERS active AuNPs using amphiphilic multidenate polymers.  The use of 
these polymeric stabilizers confer many unique properties, including controlled growth 
kinetics, increased nanoparticle stability and a wide range of possible nanoparticle sizes.  
The procedure also allows for the in situ addition of reporter dyes, spontaneously 
forming SERS active particles in a one-pot method and yielding AuNPs with high 






The preparation of gold nanoparticle (AuNPs) solutions has taken place since 
ancient times [173], although understanding of the process was not possible until 
recently with the development of highly sensitive instrumentation able to characterize 
and image the particles.  Initial applications for AuNP solutions was in the staining of 
glass or ceramics red due to the unique absorption properties of colloidal gold solutions.  
AuNP solutions were also thought to have medicinal properties, and have been used for 
the treatment of arthritis [173].  Michael Faraday, in 1857, reported the synthesis of 
colloidal gold through the reduction of chloroaurate [174].  The reduction preparation 
method has continued to be studied and major improvements were made in the past 
several decades by Turkevitch et al.  [175] and Frens [176].  Citrate (Figure 5.1a) has 
been shown to act as both a reducing agent (to reduce chloroaurate) and a coordinating 
and stabilizing ligand to bind to the surface of the AuNPs and render them colloidally 
stable in water.  Nanoparticles synthesized using this method are very monodisperse 
and show a characteristic surface plasmon resonance peak in their absorption spectra, 
as seen in Figure 5.2b.  With the introduction of the citrate reduction method (as well as 
other synthesis procedures), the preparation of AuNP solutions can be done in a rapid 




Figure 5.1. Gold nanoparticle synthesis using citrate reduction. (a) Citrate contains 
carboxylic acid functional groups (also present on the amphiphilic polymer) capable of 
gold reduction and coordination and stabilization of gold nanoparticle surfaces. (b) 
Characteristic surface plasmon resonance peak for gold nanoparticles. 
 
The interesting size-dependent electronic, optical and magnetic properties of 
gold colloids [173, 177-180], in addition to the advances in synthetic preparation 
techniques, have led to an explosion of interest in these nanoparticles and a rush to use 
them in many exciting applications.  In particular, the use of AuNPs as a biomedical 
labeling agent has received considerable attention in the past few decades.   Because of 
their strong electron absorbing properties, AuNPs have been used as TEM contrast 
agents for cell and tissue applications.  They have also been used in countless 
colorimetric assays based on the color change of gold colloid solutions upon 
aggregation.  The use of DNA-conjugated gold particles to detect low concentrations of 
nucleic acids has been extensively studied and elegant and highly sensitive assay 
techniques have been developed for this application [51, 181-184] as well as others.  
One particular assay that has seen considerable commercial success is the home 
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pregnancy test, many of which utilize gold nanoparticles for a colorimetric determination 
[185]. 
 Surface Enhanced Raman Scattering (SERS) using AuNPs is a particularly 
important technique that has generated substantial interest in the research community in 
recent years [52, 186].  Initial work by our group and others has shown an incredible 
signal enhancement factor on the order of 1014-10-15  [186, 187].   A subset of optically 
―hot‖ nanoparticles were also identified which have extremely efficient optical 
enhancement [188-191].  These discoveries have led to many studies showing single 
molecule detection using SERS AuNPs.  However, biocompatible coatings for the SERS 
particles were needed for their use in biological and medical applications.  Several 
groups have demonstrated a variety of surface coating techniques, including 
polydivinylbenzene-coatings [192] and glass shells [193].  While these designs allowed 
preliminary biological studies to be performed, several limitations remained.  Our group 
has recently developed a new class of SERS nanoparticle tags that directly address 
many of the limitations of previous efforts.  These tags are composed of large gold 
nanoparticles with dye adsorbed to the surface and a thick PEG-thiol coating to protect 
the nanoparticle and provide biocompatibility.  These SERS particles have been 
successfully used in a number of applications, including in vivo targeting and imaging of 
tumors in animal models [41]. 
In this chapter, we show a novel strategy for the one-pot synthesis of high-quality 
AuNPs and SERS tags. This method is based on the use of amphiphilic multidentate 
ligands acting as both a reducing agent for the gold solution as well as a surface coating 
for the prepared AuNPs.  By using the polymer based procedure, the reaction kinetics 
for the synthesis are dramatically changed in comparison to standard citrate reduction, 
significantly slowing the reaction and allowing interesting control of the synthesis.  The 
prepared particles are also extremely stable in a variety of conditions, including high salt 
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concentrations and high pH, likely due to the stability of the polymer coating.  
Furthermore, by changing the initial concentration of polymer in solution, the size of the 
prepared AuNPs can be tuned, allowing for the synthesis of larger particles with the 
potential for SERS activity.  Indeed, adding a SERS active dye to the large AuNP 
solution enables SERS signal to be detected. 
 
5.3 METHODS 
Synthesis of Gold Nanoparticles Using Multidentate Polymers 
 The multidentate polymer ligand, PAA-DDA, was synthesized and purified as 
previously described.  A stock solution of the polymer in basic water (pH ~8) was 
prepared and vortexed/sonicated to completely disperse the polymer.  DI water was 
added to give a final concentration of 0.15 M COOH.  Separately, a 50 mM stock 
solution of gold (III) chloride was prepared in water.  For a 10 mL reaction, 50 μL of the 
50 mM stock solution was diluted into 9.783 mL DI water and heated to 100ºC under 
vigorous stirring.  167 μL of the polymer stock solution was quickly added, to give a 10:1 
COOH:Au ratio.  The reaction was allowed to progress at 100ºC and atmospheric 
pressure for 24 hours. 
 
Synthesis of Gold Nanoparticles using Citrate Reduction 
 A stock solution of gold (III) chloride was prepared as described above.  
Separately, a solution of sodium citrate was prepared in water to yield a solution with a 
final concentration of 0.15 M COOH (0.05 M citrate).  For a 10 mL reaction, 50 μL of the 
50 mM stock solution was diluted into 9.783 mL DI water and heated to 100ºC under 
vigorous stirring.  167 μL of the citrate stock solution was quickly added, to give a 10:1 
COOH:Au ratio.  The reaction was allowed to progress at 100ºC and atmospheric 




Reaction Kinetics of Gold Nanoparticle Synthesis 
 AuNP synthesis using the multidentate polymer ligands was performed as 
described above.  500 μL aliquots were taken at various time points and transferred to 
1.7 mL eppendorf tubes. The aliquots are rapidly cooled by immediately placing the 
sample tube in an ice water bath to halt the nanoparticle growth.  Absorption spectra 
were obtained using a Uv-Vis absorption spectrometer.  The spectra were analyzed and 
surface plasmon resonance (SPR) peak and the half width half max (HWHM) of the 
absorption peak were calculated and plotted.  HWHM was defined as the width of the 
curve from the absorption peak to half of the intensity peak, measured in nanometers.  
Reaction kinetics were compared to AuNPs prepared under identical conditions, using 
traditional citrate reduction. 
 
Gold Nanoparticle Size Analysis 
 AuNP size was analyzed using both DLS and TEM.  Unstained TEM was 
performed as described for QDs.  Images of the samples were taken and analyzed using 
ImageJ to determine a size distribution for the sample and an average size for the 
coated particles.  DLS was used as previously described to measure the hydrodynamic 
diameter of the nanoparticles.  AuNP samples were prepared in water and filtered using 





Gold Nanoparticle Salt Stability 
 A stock solution of polymer-coated AuNPs was prepared in DI water, vortexed 
and sonicated for 15 minutes to disperse any loose aggregates and filtered through a 
0.45 μm filter to remove any contaminants.  Separately, a 5 M NaCl solution was 
prepared and serial dilutions were made.  Aliquots of the polymer-coated AuNP solution 
were taken and diluted into the salt solutions at a 1:1 ratio and vortexed to complete mix 
the solutions, resulting in final NaCl concentration ranging from 2.5 M to 0 M NaCl.  
Absorption spectra were then taken using a Uv-Vis absorption spectrometer.  The 
procedure was repeated for citrate stabilized AuNPs and the results were compared. 
 
Gold Nanoparticle pH Stability 
 A solution of AuNPs was prepared and filtered as described above.  Basic 
(pH~10) and acidic (pH~3) buffered solutions were prepared and 1 mL aliquots were 
transferred to a 1.7 mL eppendorf centrifuge tube. 250 μL aliquots of the AuNP solution 
were pipetted into the tubes and vortexed to mix completely.  The samples were then 
centrifuged at 5000 g for 10 minutes and observed for evidence of precipitation. 
 
Synthesis of Large Gold Nanoparticles Using Multidentate Polymers 
 AuNP synthesis using the multidentate polymer ligands was performed as 
described above.  The polymer concentration in the reaction flask was varied to 
determine the effect of polymer concentration on reaction kinetics and AuNP size.  For 
larger AuNPs, the polymer concentration was reduced to below the CMC of the polymer 





Dark Field Microscopy of Large Gold Nanoparticles 
 Large polymer-coated AuNPs were synthesized as described above.  A solution 
was prepared and vortexted/sonicated to resuspend the particles and disperse any 
aggregates.  1.5 μL of the prepared AuNP solution was pipetted onto a glass coverslip.  
A second coverslip was placed on top to form a thin film between the coverslips.  After 
waiting 10 minutes for the nanoparticles to settle, the sample was then imaged using an 
Olympus BX51 microscope for reflective mode dark field microscopy. 
 
SERS Active Gold Nanoparticle Synthesis 
 Large polymer-coated AuNPs were synthesized as described above.  A solution 
was prepared and vortexted/sonicated to resuspend the particles and disperse any 
aggregates.  Separately, a 4 μM solution of malachite green (MCG) in water was 
prepared.  The MCG solution was added dropwise to a rapidly mixing solution of AuNPs 
at a molar ratio of ~25,000:1 MCG:AuNP.  The AuNPs were allowed to precipitate and 
then resuspended in 50 mM borate buffer.  SERS spectra were obtained using a 
Advantage Raman Series system (DeltaNu) and compared to polymer-coated AuNPs 
without MCG as well as a standard MCG spectrum. 
 
5.4 RESULTS AND DISCUSSION 
Gold Nanoparticle Synthesis Using Multidentate Polymers 
 Citrate reduction has become a widely used synthesis procedure for the 
production of high quality, monodisperse AuNPs for a wide range of sizes.  However, 
AuNPs stabilized with citrate molecules are generally too unstable for use in biological 
applications and must be coated with other surface ligands or protective molecules to 
enhance their utility [41, 182, 193].  Based on our success in preparing semiconductor 
nanoparticles using amphiphilic polymers as multidentate precursors and ligands 
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(Chapter 4), we have studied the potential for using these polymers in AuNP synthesis.  
Because the polymer contains a number of carboxylic acid functional groups (as citrate 
does, Figure 5.1a), it was hypothesized that the polymer could behave in a similar 
manner, acting as a reducing agent for the gold and a surface ligand/ polymer coating 
for the gold nanoparticles.  In addition, it is expected that the prepared particles will be 
more stable than citrate stabilized AuNPs due to the multivalent binding of the functional 
groups on the particle surface and the thickness of the polymer shell. 
 Preliminary synthesis experiments were performed in water at 100°C with a 10:1 
ratio of carboxylic acid functional groups to Au atoms, a common ratio used in the citrate 
procedure.  Analysis of the absorption spectra during the reaction procedure reveals a 
gradual appearance of a peak at 540 nm, as seen in Figure 5.2a.  This peak is 
characteristic of the plasmon resonance peak seen for AuNPs, indicating the presence 
of nanoparticles.  The reaction solution, originally transparent with no color, also 
gradually obtained a deep red color, further indicating the successful synthesis of 
AuNPs.  To conclusively determine if the amphiphilic polymer can be used in the 
synthesis of AuNPs, TEM was used to examine the samples after the reaction was 
terminated.  Analysis of the TEM images revealed a large concentration of spherical 
nanoparticles, as seen in Figure 5.5a.  Upon closer examination of the samples, a 
number of interestingly shaped particles were observed.  Using the polymer synthesis 
method, nanoparticles with three, four, five and six sides were observed in addition to 
spherical particles as seen in Figure 5.2b.  Although the proportion of particles with 
these unique shapes was low, further exploration is warranted because of their unique 
optical and electronic properties [194-196].  Additional studies are needed to determine 






Figure 5.2. Gold nanoparticle synthesis using amphiphilic polymers.  (a) Absorption 
spectra over the course of the synthesis, showing the gradual emergence of a peak at 
540 nm, indicating the presence of gold nanoparticles.  (b) Nanoparticle synthesis using 
multidentate polymer results in the formation of a number of interesting shapes, with the 
majority of the population being spherical.  
 
 Another interesting observation made during the initial synthesis procedure was 
the color shift of the solution.  The reaction mixture of aqueous AuNPs synthesized using 
citrate reduction undergoes a series of color changes before finally obtaining the deep 
red color associated with colloidal gold particles.  The mixture starts as a clear or slightly 
yellow solution as a result of the chloroaurate precursor used.  The solution then 
develops a dark grey color, which transitions to purple and then finally red, as colloidal 
gold is formed.  Recent work has revealed that the deep grey/purple color of the solution 
is associated with a transient intermediate consisting of gold nanowires [197].  These 
transient nanowires eventually bud off, forming citrate-stabilized, spherical AuNPs and a 
resulting red color.  AuNPs synthesized using the amphiphilic polymers, however, do not 
undergo a grey/purple transition.  Instead, the transparent solution gradually develops a 
pink hue, which slowly intensifies until a deep red color is observed.  This can be 
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observed in the absorption spectra (Figure 5.2a), where the spectra shift only slightly 
and merely increase in intensity.   
Interestingly, altering the concentration of the polymer in solution has dramatic 
effects on the synthesis process.  For synthesis procedures using a polymer 
concentration between one and five times the CMC, stable gold nanoparticles are 
difficult to produce.  These solutions enter a perpetual grey/purple phase and are unable 
to transition to the red phase associated with colloidal gold, eventually precipitating after 
extended heating at 100°C (approximately 6 hours).  Although not completely elucidated, 
the mechanism of AuNP formation using polymer nanoparticles has been shown in this 
work to be unique compared to the citrate procedure.  It is hypothesized that the 
perpetual grey/purple phase seen in some experiments could be due to the formation of 
stable gold nanowires.  Further studies could reveal this complex mechanism and lead 
to the synthesis of novel nanomaterials. 
  
Polymer Procedure Reaction Kinetics 
 Upon successfully synthesizing AuNPs using multidentate polymers, a series of 
experiments were performed to systematically study the reaction kinetics of the 
procedure.  AuNPs were synthesized using both citrate reduction and the polymer 
method under identical reaction conditions and samples were taken during the process 
to monitor the reactions.  Synthesis using citrate reduction proceeded as expected, with 
a transition from clear to grey/purple and finally red within approximately 7.5 minutes.  
The plasmon resonance peak showed a significant decrease over the course of the 
reaction, blue-shifting approximately 50 nm as seen in Figure 5.3a.  Likewise, the half 
width half max (HWHM) of the peak dramatically decreased to approximately 40 nm for 
the prepared nanoparticles.  This peak narrowing, as seen in Figure 5.3b, corresponds 
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Figure 5.3.  Gold nanoparticle synthesis reaction kinetics using citrate reduction. (a) As 
the reaction progresses, the absorption peak (black) decreases abruptly and plateaus at 
approximately 530 nm while the HWHM significantly narrows to approximately 40 nm. 
(b) Normalized absorbance spectra of the prepared nanoparticles over the course of the 
reaction. 
 
 In contrast, the reaction kinetics seen with the use of amphiphilic polymers was 
significantly retarded, mirroring results seen during the polymer synthesis of QDs 
(Chapter 4).  In fact, the reaction progress was slower than the citrate procedure by 
nearly two orders of magnitude, requiring approximately 10 hours to reach completion.  
This considerable decrease in reactivity is likely due to the structure of the polymers in 
water and their interaction with the AuNPs.  The polymer concentrations used in these 
studies were well above the CMC of the polymer, resulting in micelles or polymer 
aggregates in solution.  As shown in Chapter 3, these polymers form aggregates in 
water with a size between 5 and 10 nm in hydrodynamic diameter.  These 
macromolecular structures could have a tremendous impact on the properties of the 
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polymer and the reaction parameters by significantly decreasing the polymer’s diffusivity.  
A decrease in the diffusion coefficient would likely lead to substantially lower nucleation 
rates.   
In addition, because the polymers are in an aggregate form, there is likely 
shielding of a portion of the carboxylic acid functional groups as they are buried in the 
interior of the polymer, effectively lowering the COOH:Au ratio in comparison to 
procedures using citrate.  The interaction of these functional groups with the surface of 
the growing nanoparticles likely plays a major role, as in the case with QDs (Chapter 4).  
Multivalent binding to the nanoparticle surface results in a much stronger polymer-
particle interaction and hinders the access of gold atoms to the surface.  The bulky 
nature of the polymer also contributes to this phenomenon because of steric hindrance, 






Figure 5.4. Gold nanoparticle synthesis reaction kinetics using polymer reduction.  (a) 
Aliquots taken during reaction procedure at various time points.  The samples slowly 
transition from a transparent to red solution as nanoparticles are formed over the course 
of approximately 10 hours. (b) Normalized absorbance spectra of the reaction mixture 
from 1.5 to 9.5 hours. (c) The absorption peak slightly red shifts (green curve) while the 
monodispersity of the sample, measured by the half width half max (HWHM) in red, 
significantly narrows as the reaction progresses.    
 
As mentioned above, the reaction appears to bypass the dark grey/purple phase, 
with simply a gradual appearance of a red color (Figure 5.4a) as the nanoparticles begin 
to form and the size distribution is focused.  This unique aspect of the synthesis 
mechanism is further demonstrated by the absorption spectra taken during the reaction 
procedure.  Unlike the citrate reduction, which showed dramatic shifts in both the 
plasmon resonance peak and HWHM, samples analyzed over the course of the polymer 
reaction show only slight changes in the absorption peak, as shown in Figure 5.4b, red-
shifting less than 10 nm over the 10 hour reaction.  As in the citrate reduction synthesis 
procedure, the size distribution of the nanoparticles narrows as the reaction progresses, 
96 
 
reaching a HWHM of almost 40 nm.  However, this change was much less significant 
because of the relatively low initial HWHM in comparison to the citrate method (Figures 
5.3a, 5.4c)  
The polymer synthesis procedure presented in this dissertation allows very tight 
control of the growth reaction, enabling the production of AuNPs in a very consistent 
manner.  These experiments further reveal that growth time plays little role in the final 
determination of the nanoparticle size.  Subsequent experiments have revealed a strong 
dependence on the initial polymer concentration in determining the ultimate size of the 
AuNPs.  These results are discussed in detail below.  
 
Gold Nanoparticle Characterization 
 To verify the quality and stability of AuNPs synthesized using the polymer 
method, samples were characterized by a variety of methods and then compared to 
particles stabilized with citrate.  AuNP size was determined using DLS as well as TEM, 
as described above.  The examination of TEM images of the polymer-coated 
nanoparticle samples (Figure 5.5a) shows a population of well dispersed, spherical 
particles with no aggregation.  Further analysis of the images revealed a nanoparticle 
size of approximately 20 nm in diameter.  These results were verified using DLS, which 
showed a fairly narrow size distribution with an average particle diameter of 40 nm 
(Figure 5.5b), considerably larger than that calculated by TEM.  This result is not 
surprising, as the hydrodynamic size of a particle is typically larger than that shown 
under TEM, due to the thickness of the electrical double layer.  In addition, the TEM 
images do not account for the thickness of the polymer coating, which is likely to be 





Figure 5.5. Gold nanoparticle size characterization. (a) Transmission electron 
micrograph (TEM) of gold nanoparticles synthesized using polymer reduction, showing 
spherical particles with no aggregation. (b) Hydrodynamic diameter histogram of a gold 
nanoparticle solution, as measured by DLS. 
 
 In addition, the stability of the polymer-coated AuNPs was measured in a number 
of environments.  Samples were prepared and transferred to buffered solutions with high 
and low pH to determine the effect of pH on the colloidal stability of the nanoparticles.  
AuNPs at high pH showed no signs of aggregation and remained colloidally stable, as 
seen in Figure 5.6a, left.  However, when pH to levels were reduced to below 4, a 
substantial amount of aggregation was observed (Figure 5.6a, right), as was the case for 
polymer-coated QDs.  This is due to the protonation state of the carboxylic acid 




Figure 5.6. Stability of polymer-coated gold nanoparticles.  (a) Polymer coated gold 
nanoparticles are stable at basic pH (left) but precipitate in acid conditions (right). (b) 
Absorbance spectra of citrate stabilized gold particles in the absence (black) and 
presence (red) of salt.  100 mM NaCl results in the precipitation of the gold 
nanoparticles. (c) Absorbance spectra of polymer stabilized gold particles in the 
presence of salt.  Even at 2.5 M NaCl concentration, the gold nanoparticles show little to 
no aggregation. 
 
 The stability of polymer-coated AuNPs was also measured in the presence of 
salt.  AuNP samples were prepared, diluted into solutions with increasing sodium 
chloride (NaCl) concentrations, and measured using absorption to determine if there was 
any aggregation.  Remarkably, the polymer-coated AuNPs showed virtually no 
aggregation in the presence of salt, with the characteristic plasmon resonance peak 
unchanged at salt concentrations as high as 2.5 M.  In contrast, AuNPs stabilized with 
citrate were extremely sensitive to the presence of salt, showing significant aggregation 
99 
 
at NaCl concentrations as low as 100 mM.  While the NaCl is able to shield the charge of 
the nanoparticles, enabling them to aggregate, it is likely that AuNPs coated with a 
polymer shell are able to resist this aggregation because of the additional steric 
repulsion from the polymer. 
 
Large Gold Nanoparticles and Synthesis of SERS-Active Particles 
 Polymer-coated AuNPs described above have a typical particle size of 
approximately 10-25 nm.  However, previous work by our group has shown that SERS 
activity for red and near infrared excitations is greater for larger particles, with a 
nanoparticle size of 60-80 nm being optimum [188].  It was hypothesized that these 
sizes may not be possible using polymers due to the growth kinetics for the polymer 
synthesis method described above.  Experiments were conducted to determine the 
feasibility of producing AuNPs in a size regime ideal for SERS activity.  Based on earlier 
observations, it was discovered that polymer concentration plays a key role in the final 
size of the AuNPs.  A series of synthesis reactions were performed, gradually 
decreasing the polymer concentration and observing the effects on nanoparticle size.  
As seen in Figure 5.7a, a significant difference is seen in the solutions as the polymer 
concentrations are decreased (left to right).  AuNP solutions prepared in this manner 
have an iridescent orange color, indicative of larger gold nanoparticles.  These 
nanoparticles precipitate under mild centrifugation, further supporting the conclusion that 




Figure 5.7. Synthesis of large gold nanoparticles.  (a)  Series of gold nanoparticles, 
showing a shift in color from red to an iridescent orange as polymer concentration is 
decreased (left to right), indicating the formation of larger particles.  (b) Transmission 
electron micrograph (TEM) of large, polymer-coated gold nanoparticles in water. (c) 
Analysis of the TEM shows a relatively monodisperse sample with an average particle 
diameter of 175 nm with a standard deviation of 25 nm, as shown in the size histogram. 
 
 TEM of the prepared AuNPs was used to verify the particle size for these 
samples and determine if the nanoparticles were suitable for use as SERS tags.  
Examination of the TEM images showed uniform and monodispersed spherical particles, 
as seen in Figure 5.7b.  Analysis of the images revealed AuNPs with a mean diameter of 
101 
 
175 nm and a standard deviation of 25 nm (Figure 5.7c), confirming the synthesis of 
large particles suitable for preliminary SERS studies.  Additional studies have shown that 
the synthesis of large AuNPs can occur when the polymer concentration is reduced to 
the CMC or lower.  At these lower concentrations, the polymer is no longer in large 
aggregates, limiting its ability to shield the forming nanoparticles and allowing for their 
increased size. 
 Although the polymer synthesis method was capable of producing particles in the 
appropriate size regime needed for SERS activity, an additional hurdle remained for the 
preparation of SERS active tags.  Raman dyes must have access to the surface of the 
AuNP to produce a strong SERS signal.  Because the polymer layer was shown to 
protect the nanoparticle very effectively, presence of the polymer could block access of 
the dye to the particle surface, preventing efficient SERS signal.  It was hypothesized 
that the larger particles, synthesized using a lower concentration of polymer, would have 
pockets available for the dyes to access.  To prepare SERS active particles, large 
polymer-coated AuNPs were synthesized as described above.  A AuNP solution was 
then prepared and a dilute malachite green (MCG) solution was added dropwise, as 






Figure 5.8. Polymer-coated SERS active gold nanoparticles for imaging applications.  
(a) Dark field microscopy shows uniform, monodispersed nanoparticles with no 
aggregation.  (b) Raman spectra of gold particles (red), malachite green (green) and 
polymer-coated SERS active particles after incorporation of malachite green. 
 
 Samples were analyzed using dark field microscopy to determine the dispersity 
of the particles and verify the absence of large aggregates.  These AuNPs were 
extremely bright and uniform under dark field microscopy, showing monodispersed 
particles with no aggregation, as seen in Figure 5.8a.  Raman spectra of the particles 
were then recorded to determine if the AuNPs were SERS active.  Polymer-coated 
AuNPs with no MCG showed no raman spectra (Figure 5.8b, red), as expected.  In 
contrast, polymer-coated AuNPs labeled with dye showed a distinct raman signature for 
MCG (Figure 5.8b, black), nearly identical to the reference MCG spectrum (Figure 5.8b, 
green).  These data show that a one-pot synthesis of polymer-coated, SERS active 
AuNPs is possible.  These nanoparticles could have significant applications in the fields 
of in vitro and in vivo diagnostics, and the results presented here and in Chapter 4 open 






In conclusion, we have reported a new synthetic procedure for the preparation of 
AuNPs based on the use of amphiphilic multidentate ligands.  The novel features 
associated with the use of polymeric stabilizers are controlled growth kinetics, increased 
nanoparticle stability and a wide range of possible nanoparticle sizes.  This procedure 
also allows for the synthesis of large AuNPs suitable for use as SERS active tags.  
Indeed, upon the addition of a reporter dye, SERS active particles are spontaneously 
formed in a one-pot procedure, yielding AuNPs with high contrast under dark field 
microscopy and distinct Raman signatures. 
 





NOVEL NANOPARTICLE SURFACE CHEMISTRIES TO 
ELIMINATE NONSPECIFIC BINDING 
 
6.1 ABSTRACT 
Quantum dot (QD) nanocrystals are promising fluorescent probes for multiplexed 
staining assays in a number of biological applications.  However, nonspecific QD binding 
to cellular membranes, organelles and biomolecules remains a limiting factor in 
detection sensitivity and specificity.  In this chapter, we show a new class of hydroxyl (-
OH) coated QDs for minimizing nonspecific cellular binding and for overcoming the bulky 
size problems encountered with current surface coatings.  The hydroxylated QDs are 
prepared from carboxylated (-COOH) QDs via a hydroxylation and crosslinking process. 
With a compact hydrodynamic size of 13-14 nm (diameter), they are highly fluorescent 
(>60% quantum yields) and stable under both basic and acidic conditions.   Using 
human cancer cells as well as biological staining buffers and human plasma, we have 
evaluated their superior nonspecific binding properties against that of carboxylated, 
protein-coated, and polyethylene glycol (PEG)-coated QDs.  Quantitative cellular 
staining data indicate that the hydroxylated QDs result in a dramatic 140-fold reduction 
in nonspecific binding relative to that of carboxylated QDs, and a moderate 10-20 fold 
reduction relative to that of PEG- and protein-coated QDs in cells.   
 
6.2 INTRODUCTION 
With the development of novel coating strategies which can render nanoparticles 
soluble in water [80, 81, 83, 84, 108, 111, 115, 153, 198-202], QDs are quickly being 
designed as fluorescent labeling agents for a broad range of biological applications.[46, 
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48, 49, 53, 80, 81, 83-85, 87, 88]  This broad interest is driven by their unique optical 
and electronic properties such as size-tunable light emission, superior signal brightness, 
resistance to photobleaching, and simultaneous excitation of multiple fluorescence 
colors [46, 48, 87, 88], which make them superior to traditional organic dyes for many 
applications.  Recent advances in QD synthesis [103-105, 107, 124, 166, 167, 170-172] 
and coating strategies have led to highly bright and stable QD probes that are well suited 
for multiplexed molecular profiling of intact cells and clinical tissue specimens [54, 55, 
90, 97-100].  In contrast to in-vivo clinical imaging, where the potential toxicity of 
cadmium-containing nanoparticles is still a major concern and will likely hinder clinical 
use in the near future, histological and cellular staining as well as solution assays are 
performed on in-vitro or ex-vivo clinical patient samples.  Because potential toxicity is not 
a concern for these samples, the use of multicolor QDs as ultrasensitive probes for 
tissue, cell and fluid samples is likely one of the most important and clinically relevant 
applications in the near term [54, 55, 99, 100].  However, a major problem for this 
application is that QD probes tend to be ―sticky‖ and often bind nonspecifically to cellular 
membranes, proteins, and extracellular matrix materials.  In particular, nanoparticles with 
highly charged functional groups, such as carboxylic acids and amines, have been 
shown to exhibit strong nonspecific binding to various cells and tissues [110, 203-205] 
as well as proteins in serum and blood.  This nonspecific binding problem causes a high 
level of background fluorescence that degrades the signal-to-noise ratio and limits 
tagging specificity and detection sensitivity.   
A number of surface encapsulation methods have been used for QD 
solubilization and bioconjugation, including direct ligand-exchange reactions with small 
molecules, such as mercaptoacetic acid [81], dihydrolipoic acid [115] and 
polyethylenimine (PEI) [110], and indirect surface encapsulation using silica, lipids, and 
amphiphilic polymers [53, 80, 81, 83, 110-113].  One strategy commonly employed to 
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reduce the nonspecific binding of nanoparticles is the attachment of polyethylene glycol 
(PEG) [53, 57, 58, 203], a nontoxic and hydrophilic polymer that is commonly used to 
improve drug biocompatibility and systemic circulation [58, 206-208].  PEGylated QDs 
have nearly neutral surface charges and are able to maintain colloidal stability under 
various experimental conditions, such as acid and base as well as high concentrations of 
salt, through steric repulsion.  Although recent work has shown the successful use of 
PEGylated QDs for both in vitro [53, 203] and in vivo [83-85, 209, 210] applications, 
nonspecific binding to biomolecules and complex intracellular and extracellular materials 
still exists and remains a bottleneck to increasing the signal-to-noise ratio and improving 
detection sensitivity and specificity [54].  In addition, PEG-coated nanoparticles have 
significantly larger hydrodynamic sizes than the uncoated nanoparticles, often more than 
doubling the particles’ hydrodynamic size.  This increased size could prevent the probes 
from accessing biological targets deep within complex tissue and cellular structures.   
In contrast, small nanoparticles often rely on a highly negative or positive surface 
charge to maintain colloidal stability and prevent particle aggregation through 
electrostatic repulsion.  This presents a problem for the use of these nanoparticles in 
complex biological environments, where biomolecules are highly charged or have 
charged regions necessary for their function. To address these problems, we have 
investigated the role of charge in QD-biomolecule interactions and have shown that the 
nonspecific binding of nanoparticles in cells, tissues and other complex biological 
samples can be minimized by reducing the surface charge of the nanoparticles.  
Moreover, through crosslinking and altering the surface chemistry of polymer coated 
QDs, we can increase the stability of the nanoparticles while maintaining a small 
hydrodynamic size.  In this chapter, we show that nearly neutral hydroxyl (-OH) surface 
coatings can be used to minimize nonspecific cellular binding of QDs, and also to 
overcome the size problem associated with PEG coatings.  These hydroxylated QDs are 
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prepared from traditional carboxylate-coated QDs via a hydroxylation and crosslinking 
process, which also serves to increase the integrity of the polymer coating.  We have 
systematically studied the effects of hydroxylation on the physical and optical properties 
of QDs, including surface charge, hydrodynamic size, colloidal stability and fluorescence 
quantum yield.   
Additionally, we have studied the effects of surface hydroxylation on the 
nonspecific binding of quantum dots in biological samples and optimized them for use in 
multiplexed imaging studies.  Using human cervical cancer cells (cultured HeLa cells), 
we have evaluated their nonspecific binding properties in comparison with carboxylated 
QDs and protein-coated QDs (coated with streptavidin, PEG-antibodies, or PEG-
peptides).  This new class of QDs leads to a dramatic 140-fold reduction in nonspecific 
cellular binding relative to that of carboxylated QDs, a 20-fold reduction relative to 
streptavidin-QDs, a 16-fold reduction relative to PEG-Ab QDs, and a 13-fold reduction 
relative to PEG-peptide QDs (QTracker).  We have also shown a significant reduction in 
binding to components in common biological staining buffers as well as human plasma. 
 
6.3 METHODS 
QD Synthesis, Encapsulation and Transfer to Water 
CdSe/CdS/ZnS QDs were synthesized using methods described above.  An 
aliquot of the crude QD solution was then purified using liquid-liquid extraction in hexane 
and MeOH and then precipitated and transferred to CHCl3 using methods described 






Surface Hydroxylation and Crosslinking 
Purified QDs (made in our lab or carboxyl-coated Qdots from Invitrogen) were 
diluted in deoinized water for surface modification/hydroxylation.  Briefly, 100 pmol of 
QDs was diluted to a final concentration of 100 nM.  Approximately 1 mg of N-
hydroxysulfosuccinimide sodium salt (Sulfo-NHS) and 12 mg N-(3-
Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDAC) were added to the QD 
solution and were mixed thoroughly.  For hydroxylation and crosslinking, 11.5 mg of 1,3-
amino-2-propanol (DAP) was dissolved in deionized water and added slowly to the QD 
solution under vigorous stirring.  The reaction mixture was allowed to react for 24 hours 
and was then dialyzed against 50 mM borate buffer to remove excess reactants and 
byproducts.  To vary the degree of hydroxylation, EDAC and DAP amounts were 
decreased appropriately.  To perform the hydroxylation reaction without crosslinking, 3-
amino-1,2-propanediol (APD) or a similar compound can be used. 
 
Gel Electrophoresis 
QDs were evaluated with a horizontal submerged gel electrophoresis apparatus 
(Mini-SubCell GT, BIO-RAD) using a 0.7% (w/v) agarose gel in tris-acetate-EDTA (TAE) 
buffer.  Briefly, a 250 mL beaker was charged with 0.35g of agarose, to which 50 mL of 
1X TAE buffer at pH 8.5 was added.  The solution was then covered with a 50 mL 
beaker and heated in a microwave until completely melted, approximately 1 minute.  The 
molten agarose was allowed to stand at room temperature for 10 minutes, at which point 
50µL of Tween-20 was added for a final concentration of 0.01% (v/v).  The solution, 
when at ~55ºC, was cast into a gel tray with a 1.0 mm 15 well comb and allowed to 
solidify.  The gel was placed in the agarose electrophoresis tank and sufficient 1X TAE 
buffer was added to the tank to just cover the top of the gel.  For each well, 20 µL of the 
QD samples at 50 nM were mixed with 5µL of 5X TAE loading buffer (5X TAE, 25% (v/v) 
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glycerol, 0.25% (w/v) Orange-G at pH 8.5) by pipetting before being loaded into the gel.  
The gel was resolved at 100 V for 30 minutes (PowerPak Basic, BIO-RAD) and then 





Figure 6.1. Quenching hydroxylation procedure using hydroxylamine.  (a) Relative 
mobility of quantum dots in a gel shift assay as a function of hydroxylamine 
concentration.  (b) High concentrations of hydroxylamine result in immediate quenching 
and gel shifts consistent with COOH-coated quantum dots. Decreasing the 
hydroxylamine concentration allowed the hydroxylation to progress, as evident by the 
decreased mobility of hydroxyl quantum dots. 
 
 A QD hydroxylation reaction was prepared, as described above, without EDAC.  
Separately, a stock solution of hydroxylamine in water was prepared and serial dilutions 
were made.  5 μL of the solutions were pipetted into 0.7 mL eppendorf tubes.  EDAC 
was then added to the reaction solution as described in the hydroxylation method.  15 μL 
aliquots were taken immediately after the addition of EDAC and transferred to the 
eppendorf tubes containing the hydroxylamine solutions to quench the reaction.  After 3 
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hours, the quenched reaction samples were analyzed using gel electrophoresis, as 
described above.  Gel shifts were measured and compared to COOH coated QDs 
(Figure 6.1).   
 
Reaction kinetics of hydroxylation reaction. 
A stock solution of 4 M hydroxylamine in water was prepared to act as a reaction 
quencher.  5 μL of the quenching solution was pipetted into 0.7 mL eppendorf tubes.  
Separately, a QD hydroxylation reaction was prepared, as previously described.  15 μL 
aliquots of the reaction solution were taken at various time points and transferred to the 
quenching solution to halt the reaction progression.  The quenched aliquots were then 
analyzed using gel electrophoresis and gel shifts were measured. 
 
Quantum Yield 
  The Quantum Yield (QY) of QDs was determined experimentally by comparison 
to dyes with known QY.  Briefly, a concentration series of dye with known QY that is 
close in emission to the QD being tested was prepared.  Absorption at the planned 
excitation wavelength and emission spectra were recorded for each of the samples 
using a Uv-Vis absorption spectrometer and spectrofluorometer, respectively.  The 
integrated fluorescence intensity (area under fluorescence spectrum) was calculated and 
plotted against the absorption to generate a line with slope, mST.  The procedure was 
repeated for a concentration series of QDs and results plotted to give a slope, mQD.  QD 





                               Equation 6.1 
 
assuming identical solvents. 
 
Cell Fixing and Staining 
HeLa cells (ATCC number CCL-2) were cultured in RPMI media with 10% fetal 
bovine serum (FBS) at 37 ºC (5% CO2) and grown in an 8-well chamber slide.  After 24 
hours for seeding, the cells were washed with 1X PBS and fixed with 3.7% formaldehyde 
and 0.1% triton X in 1X phosphate buffered saline (PBS) for 5 minutes.  The fixative was 
then aspirated and the cells washed with 1X PBS 3 times for 5 min each.  A 2% bovine 
serum albumin (BSA) blocking solution in 1X PBS was added to the wells for 20 min and 
then aspirated.   QDs were diluted in the blocking solution to the desired concentration 
and incubated with the cells for 20 min.  The QD staining solution was aspirated and the 
cells were washed with 1X PBS 3 times for 5 min each.  A 1 μg/mL solution of 4’,6-
diamidino-2-phenylindole dihydrochloride (DAPI) in deionized water was added to the 
wells and incubated for 5 min for nuclear staining.  The DAPI solution was then aspirated 
and the cells were washed for 5 min with deionized water.  The slide was mounted and 
prepared for fluorescence microscopy.    
 
QD Cell Binding Assays.   
For quantitative analysis of nonspecific QD binding to cells, a fluorescent 
microplate reader (Synergy 2 Multi-detection Microplate Reader, Biotek Instruments) 
was used.  Briefly, HeLa cells were cultured in a clear bottom 96 well plate for 24 hours, 
fixed, blocked and stained as described in the cell staining experiment protocol.  DAPI 
nuclear staining was performed as described above to correct for variations in cell 
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densities.  QD concentrations from 0 to 20 nM were used in replicates of six (n = 6).  The 
fluorescence intensity from the QDs was measured, normalized using the DAPI 
fluorescence intensity, and background subtracted to determine the intensity of 
nonspecific staining. 
 
QD-Biological fluid Binding Assays 
QD solutions with various coatings (-COOH, -OH, Streptavidin (Strep) and 
PEG/antibody) were prepared at 100 nM.  Separately, stock solutions of common 
biological fluids (5% goat serum/2% BSA, 6% BSA, human plasma) were prepared.  QD 
solutions were diluted 1:5 into each of the biological fluids, vortexed to mix completely 
and allowed to incubate at room temperature for 2 hours.  After incubation, aliquots of 
the samples were taken and used in gel electrophoresis.  Relative migration rates for the 
samples were compared to QD samples that had been incubated in 1x PBS. 
 
6.4 RESULTS AND DISCUSSION 
A number of different techniques have been employed to protect the surface of 
semiconductor QDs and render them soluble in water for use in biological applications.  
These techniques generally fall into two categories: (a) exchanging the hydrophobic 
ligands on the QD surface with hydrophilic small molecule ligands, or (b) coating the 
nanoparticles with an amphiphilic polymer that can interact with both the hydrophobic 
ligands and the surrounding aqueous environment.  While coating procedures that 
preserve the hydrophobic ligands have shown improved optical properties compared to 
QDs produced using ligand exchange procedures[116], the resulting nanoparticles are 
typically larger in size and may not perform well for complex samples such as cells and 
tissues.  The size of these nanoparticles is further increased by surface treatments that 
are designed to reduce nonspecific binding.  These treatments generally involve 
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attaching proteins (such as streptavidin) or large hydrophilic polymers such as 
polyethylene glycol (PEG) to the QD surface which have been shown to reduce, but not 
eliminate, nonspecific binding.   
 
Surface Coating Chemistry 
Nanoparticle surface charges are believed to play a critical role in the nonspecific 
binding process, because QDs with either highly negative or positive charges show 
significant nonspecific binding to cells and tissues [110, 203-205].  This is not 
unexpected, as many proteins and other molecules inside and outside the cell are 
charged or have charged regions which are important for a variety of biological 
processes [211].  Electrostatic interactions between proteins or other molecules play a 
significant role in molecular recognition, control of protein phosphorylation and the 
enhancement of catalytic rates [212].  These charged regions likely interact with 
nanoparticles electrostatically, leading to considerable nonspecific binding as observed 
for highly charged QDs.  In this chapter, we have investigated nonspecific binding of 
QDs to biomolecules in cells and biological fluids and developed new coating methods to 
minimize nonspecific binding while maintaining the small size and stability of the QD 
probes.   
Polymer-coated QDs produced using the methods described in Chapter 3 show 
excellent optical and colloidal properties when transferred to water.  However, the 
nanoparticles have carboxylic acid functional groups covering their surface and are 
highly negatively charged.  Initial staining of fixed cells using these QDs showed intense 
nonspecific binding, as expected.  Because surface charge is believed to play a crucial 
role, a surface coating strategy was developed to reduce the charge of the nanoparticles 
while maintaining colloidal stability.  As shown in Figure 6.2a, carboxylic acid functional 
groups of polymer coated QDs (as described in Chapter 3)  were modified with a small 
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hydroxyl-containing molecule (1,3-diamino-2-propanol or DAP) to yield QDs with 
hydroxyl functional groups on the surface.  Based on a geometric model of the polymer 
and the QD surface area, we have estimated that each QD is covered with about 150 
amphiphilic polymer molecules, leading to approximately 2500 carboxylic acid functional 
groups (each polymer molecule has ~15 -COOH groups).  These -COOH groups are 
converted to -OH groups by a hydroxylation and crosslinking process, creating a cage-
like shell that locks the polymer coating in place.  The hydroxylated QDs are stable for 
over 6 months in borate buffer solution at 4°C. They also show no aggregation in acidic 
environments, which has been a problem for traditional QDs with carboxylic acid 
functional groups (due to protonation at low pHs) [116] .  Transmission electron 
microscopy (TEM) clearly shows polymer-encapsulated QDs with an average diameter 
of ~13 nm, as seen in Figure 6.2b.  Fluorescence microscopic imaging further reveals a 
characteristic blinking behavior for immobilized QDs on a glass slide, indicating that the 





Figure 6.2. Surface coating chemistry and structure of polymer-encapsulated quantum 
dots (CdSe/CdS/ZnS). (A) Schematic diagram showing conversion of carboxylated 
quantum dots (coated with poly(acrylic acid)-octylamine) to hydroxylated and crosslinked 
quantum dots.  The small-molecule agent for hydroxylation is 1,3-diamino-2-propanol. 
(B) Transmission electron micrograph (TEM) showing the structure of encapsulated 
quantum dots after surface hydroxylation and crosslinking.  
 
Hydroxylation Kinetics 
 To confirm the success of the hydroxylation procedure and optimize the reaction 
parameters, the reaction kinetics of the process was analyzed.  Sample aliquots were 
taken and the reaction was quenched to determine the progress of the reaction at 
various time points.  These samples were analyzed using gel electrophoresis and the 
migration data was plotted as a function of time.  Gel migration was expected to 
decrease as the reaction progressed, due to the replacement of carboxylic acid 
functional groups (which are highly negatively charged and run quickly towards the 
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positive electrode of the gel) with hydroxyl functional groups, which have a more neutral 
charge and thus run slower in the gel.   
 
 
Figure 6.3. Quantum dot hydroxylation reaction kinetics. (a) Quantum dot gel migration 
as a function of time.  Reaction kinetics follow simple exponential decay rate, with 
yo=1.05, a=0.77 and b=0.063.  These parameters give a ―half-life‖ of approximately 11 
hours. (b) Gel image showing decrease in gel migration and only slight band broadening 
as the hydroxylation progresses. 
 
As expected, gel migration noticeably decreased as the hydroxylation reaction 
progressed, as seen in Figure 6.3b.  Plotting the results as a function of time and fitting a 
curve to the data points (Figure 6.3a) showed the reaction kinetics follow a simple 
exponential decay model: 
 
                     Equation 6.2  
 
Based on this equation, the reaction has a ―half-life‖ (in this case, the time at which half 
of the carboxylic acid functional groups are converted to hydroxyl groups) of 
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approximately 11 hours.  It is not surprising that the reaction kinetics resemble an 
exponential decay model, as steric hindrance may play a role in the process.  Because 
of the polymer coating, some carboxylic acid functional group will be unobstructed on the 
surface of the particle, while others may be buried deeper within the polymer shell.  As 
the reaction progresses, it is likely that the easily accessed functional groups are quickly 
converted, as shown in the sharp decrease in gel migration at shorter time points.  
Groups deeper within the polymer shell are not as easily accessed, resulting in a slowing 
of the reaction progress as it asymptotically approaches completion, as seen in the 
longer time points (Figure 6.3a).  These results suggest that the hydroxylation procedure 
should be allowed to progress at least 11 hours to replace the majority of carboxylic acid 
groups with hydroxyl groups. 
 
Quantum Dot Size, Charge and Optical Properties 
To verify that the surface charge had been reduced and the optical and colloidal 
properties of the QDs were maintained, samples were taken and characterized using a 
variety of methods.  As shown in Figure 6.4, polymer encapsulation and subsequent 
hydroxylation have no major effects on the QD’s optical properties such as UV-Vis 
absorption and fluorescence emission.  Polymer coating of the hydrophobic QDs and 
subsequent transfer to water resulted in a relatively small decrease in fluorescence 
quantum yield (from ~80% for hydrophobic QDs to ~60-65%).  The hydroxylation 
procedure showed no noticeable decrease in fluorescence quantum yield compared to –
COOH QDs.  Importantly, both the coating process as well as hydroxylation procedure 
have no broadening effects on the spectral width of the QDs (Figure 6.4), with –OH QDs 





Figure 6.4.  UV-Vis absorption (left sloping curves) and fluorescence emission spectra 
(symmetric peaks at 640 nm) of (a) hydrophobic quantum dots in chloroform, (b) 
solubilized quantum dots in buffer solution, and (c) hydroxylated quantum dots in buffer 
solution.   Note that the water-solubilized quantum dots and the hydroxylated quantum 
dots have nearly identical fluorescence emission spectra with a quantum yield of 65% 




This surface treatment also has little or no effect on the overall particle size as 
measured by dynamic light scattering (DLS). In fact, the hydrodynamic sizes (13-15 nm 
in diameter) of the hydroxylated QDs are nearly the same or slightly smaller than that of 
the carboxylated QDs (14-16 nm).  Although surface hydroxylation was expected to 
increase the physical size of the particles slightly, this result is not unexpected because 
the process also reduces the particle surface charge and the electrical double layer 
thickness (thus the hydrodynamic radius).  In contrast, QDs coated with PEG and/or 
proteins often have hydrodynamic sizes of 25-30 nm, about twice the size of 




Figure 6.5.  Size and charge comparison of quantum dots with varying surface coatings. 
(a) Hydrodynamic size data obtained from hydroxylated QDs, carboxylated QDs, 
streptavidin-coated QDs, QTracker QDs, and antibody-conjugated QDs by using 
dynamic light scattering measurement.  (b) Gel electrophoresis migration data 
corresponding to the different types of QDs in (a).   
 
The decrease in surface charge after hydroxyl modification was further confirmed 
by zeta potential and gel electrophoresis measurements.  QDs with carboxylic acid 
surface groups have a measured zeta potential of -40 mV at pH 8.5, consistent with 
previously reported values [116], while the hydroxylated nanoparticles show a significant 
decrease in surface charge, with a zeta potential of -20 mV at pH 8.5.  For gel 
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electrophoresis measurements, QDs coated with a PEG layer are expected to run very 
slowly due to their larger sizes and more neutral zeta potentials.  Likewise, streptavidin-
conjugated nanoparticles are expected to run slower because of their larger sizes and 
reduced charges from protein shielding.  QDs with carboxylic acid surface groups are 
expected to run most rapidly towards the positive electrode because of their small sizes 
and high negative charges. In comparison, the hydroxylated QDs should run more slowly 
than the –COOH QDs due to their reduced surface charges, despite being identical in 
size.  Indeed, gel electrophoresis studies (as seen in Figure 6.5b) reveal that 
carboxylated QDs migrate the farthest in distance, in agreement with their strongly 
negative zeta potential and small size.  The hydroxylated QDs migrate less than the 
carboxylic acid QDs, but more than the protein or PEG-coated dots, most likely due to 
their smaller size.  Streptavidin and secondary antibody conjugated QDs show a slow 
migration toward the positive electrode, suggesting a net negative surface charge.  This 
negative charge suggests that that the antibody conjugate QDs are sparsely coated with 
PEG because heavy PEGylation would shield the surface of the QDs and produce 
nanoparticle with nearly neutral zeta potentials.[116]   
 
Nonspecific Cellular Binding 
To determine if hydroxylation can reduce the nonspecific binding of nanoparticles 
in cells, tissues and biological fluids, we have used human cancer cells to evaluate the 
nonspecific binding properties of QDs with different surface coatings.  As shown in 
Figure 6.6, carboxylated QDs show very high nonspecific cellular binding when 
incubated at a concentration of 20 nM (Figure 6.6a,b); significant nonspecific binding is 
also observed at QD concentrations lower than 2 nM.  In contrast, there is no detectable 
nonspecific binding for the hydroxylated QDs at similar concentrations (Figure 6.6c,d).  
Note that DAPI nuclear staining is used to ensure an equivalent cell density between the 
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samples.  The QD concentration was then increased to 100 nM to determine if any 
nonspecific binding could be detected for the hydroxyl modified QDs.  Even at this high 




Figure 6.6.  Fluorescence microscopy images of hydroxylated and carboxylated 
quantum dots nonspecifically bound to fixed human HeLa cells.  (a, b): Carboxylated 
quantum dots with (a) and without (b) DAPI counter staining of cell nuclei, showing 
intense nonspecific cellular binding.  (c. d): Hydroxylated quantum dots with (c) and 
without (d) DAPI counter staining of cell nuclei, showing the absence of nonspecific 
cellular binding. 
 
For quantitative and statistical analysis of these results, we then used a 
fluorescence microplate assay to objectively measure a large population of QD-stained 
cells.   As shown in Figure 6.7a, protein and PEG-coated QDs show a reduced level of 
nonspecific binding in comparison with carboxylated nanoparticles.  Remarkably, our 
123 
 
hydroxylated QDs show virtually no nonspecific binding in the microplate assays, 
corroborating the fluorescence microscopy results shown in Figure 6.6.  Another 
interesting result is that nonspecific QD binding has an approximately linear relationship 




Figure 6.7.  Quantitative evaluation and comparison of nonspecific cellular binding for 
various quantum dot surface coatings. (a)  Normalized fluorescence staining at 20 nM 
quantum dot concentration as measured by microplate assays. (b)  Plots of nonspecific 
cellular binding signal intensities as a function of quantum dot concentration. 
 
Surface Charge Variations 
To investigate how the degree of hydroxylation would affect cellular nonspecific 
binding, we then prepared a series of QD samples with increasing hydroxyl densities.  
As shown in Figure 6.8a, the degree of hydroxylation was measured by zeta potential 
and gel electrophoresis, and its effect on nonspecific QD binding was analyzed using 
fluorescence microplate assays.  Fully carboxylated QDs have the highest negative 
charge, and migrate the farthest on a gel.  As the degree of hydroxylation is increased, 
the net surface charge is reduced, hindering QD migration in the gel.  An interesting 
finding is that the migration distance plateaus as the degree of hydroxylation approaches 
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100%. This plateauing effect is likely due to the increasing difficulty to hydroxylate the 
carboxylic acid groups due to steric hindrance, as described above.  As expected, 
nonspecific binding is dependent on the degree of surface hydroxylation, with fully 
hydroxylated QDs showing virtually no nonspecific binding.  These results are consistent 
with previous reports for highly charged nanoparticles and the hypothesis that charge 




Figure 6.8.  (a) Gel electrophoresis data for quantum dots with increasing degrees of 
hydroxylation, from 100% -COOH (left) to 100% -OH (right).  (b) Nonspecific cellular 





Nonspecific Binding in Biological Fluids 
 Nonspecific binding has also been observed in a number of biological 
environments (such as blood, serum and plasma) as well as in tissue staining buffers, 
presenting a problem for assays in which QDs or other nanoparticles encounter these 
fluids.  Similar trends in binding are seen as with the cellular studies discussed above, 
with highly charged particles exhibiting strong nonspecific binding.  To determine if the 
hydroxyl coated QDs were able to reduce this binding, studies were conducted in 
common tissue staining blocking buffers as well as human plasma, comparing the 
hydroxyl QDs with COOH QDs and other commercially available nanoparticles.  After 
incubation in the fluids, samples of the nanoparticles were taken and analyzed using gel 
electrophoresis, measuring any change in migration as compared to particles incubated 
in 1x PBS.  As seen in Figure 6.9, hydroxyl QDs performed exceptionally well in 6% BSA 
and 5% goat serum with 2% BSA, showing virtually no change in gel migrations.   
 
Figure 6.9. Nonspecific binding of quantum dots in staining buffers.  (a) Relative 
migration and (b) gel image of quantum dots with different surface coatings when 
incubated in 6% BSA (black) and tissue staining blocking buffer (grey) as compared to 
gel migration of particles in PBS.  Hydroxyl-coated quantum dots showed virtually no 





Commercially available QD products (with streptavidin coatings and PEG) showed a 
moderate increase in gel migration (10-40% change), indicating the binding of proteins 
to the QDs.  This change in migration is likely due to both a change in the overall surface 
charge of the nanoparticles as well as the size.  Carboxyl coated QDs performed very 
poorly, as expected, with decreases in migration of over 50% in the presence of the 
staining buffers.  This is likely due to both an increase in size as well as charge shielding 
as a result of the adsorption of biomolecules to the QD surface. 
Similar results were seen when exposing the nanoparticles to human plasma 
(Figure 6.10).  Hydroxyl coated QDs showed very little nonspecific adsorption of 
biomolecules, with gel migration changes of less than 10%.  Commercially available 
nanoparticles performed moderately well (Figure 6.10a), with a 15-30% change in gel 
migration.  The carboxyl-coated QDs performed even worse in plasma, with a change in 
migration of over 80% and a significant portion of the particles aggregated and stuck in 







Figure 6.10. Nonspecific binding of quantum dots in biological fluids.  (a) Relative 
migration and (b) gel image of quantum dots with different surface coatings when 
incubated in human plasma as compared to gel migration of particles in PBS.  Hydroxyl-
coated quantum dots showed virtually no change in mobility, indicating little to no 
nonspecific binding to biomolecules present in the plasma. 
 
6.5 CONCLUSIONS 
In this chapter, we have described the development of a new class of 
hydroxylated QDs to minimize nonspecific cellular binding and to maintain the small size 
of QD probes.  These particles were prepared from carboxylated (-COOH) dots via a 
hydroxylation and crosslinking step. The hydroxyl-coated QDs have compact sizes (13-
14 nm hydrodynamic diameter), and are bright (65% quantum yields) and very stable 
under both basic and acidic conditions.  Quantitative data from human cancer cells 
indicate that the use of hydroxylated QDs results in a dramatic 140-fold reduction in 
nonspecific binding relative to that of carboxylated QDs, and a moderate 10-20 fold 
reduction relative to protein and PEG-coated QDs.  Our results also indicate that surface 
charge plays a significant role in the nonspecific binding of these nanoparticles to 
cellular components.  We expect these new nanoparticles to be useful in a range of 
biological applications where nonspecific binding is a major problem, such as staining in 
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cells and tissues, sensitive detection in body fluid samples (blood, urine, etc.), as well as 
live cell imaging.  In particular, significant opportunities exist in using these hydroxylated 
QD probes for multiplexed disease diagnostics.  In particular, QD probes can be used to 
measure a panel of biomarkers in intact cancer cells and tissue specimens, allowing a 
correlation of traditional histopathology and molecular signatures.  With minimized 
nonspecific binding and background interference, QD probes are especially well suited 
for analyzing cancer biomarkers that are present at low concentrations or in small 
numbers of cells.  Recent work by Xing et al. has shown the simultaneous staining of 4 
different biomarkers for intact cancer cells [54, 99].  Work is also on going to develop 







LOW BINDING, HYDROXYL QUANTUM DOTS FOR 
STAINING APPLICATIONS 
7.1  ABSTRACT 
Histopathology is a powerful diagnostic method that allows pathologists to 
accurately diagnosis a number of diseases by microscopically observing diseased tissue 
samples.  Significant progress has been made in the development of new instruments 
and technologies to aid in the analysis of the samples.  However, significant hurdles 
remain in the rapid and quantitative analysis of multiple disease biomarkers.  Because of 
their unique optical and colloidal properties, QDs present an exciting opportunity to 
develop the next generation of histopathology tools and could enable rapid and 
quantitative detection of multiple disease markers.  In this chapter, we explore the use of 
a cyanogen bromide (CNBr) bioconjugation technique for the coupling of antibodies or 
other targeting molecules to the surface of hydroxyl-coated QDs.  Preliminary results are 
promising and this technique could lead to a new class of targeted nanoparticles for use 
in clinical pathology. 
 
7.2 INTRODUCTION 
Histology has been performed for more than 100 years for the examination of 
tissue samples.  With advances in the field of microscopy and the availability of new 
instruments and materials, microscopists have developed a number of ingenious 
techniques and procedures for enhancing the contrast of important tissue structures and 
imaging components of interest within the tissue sample.  These technologies have 
allowed the field of histopathology (the microscopic examination of tissues in order to 
study or diagnose disease) to develop at a rapid pace, with the histological examination 
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of patient samples being common place in the clinic today.  Tissue samples can be 
obtained from patients in a number of ways, particularly using surgical biopsy, and the 
sample is preserved for later study using a variety of techniques.  The most commonly 
used fixative in histopathology is 10% formalin, which preserves the tissue structure by 
crosslinking proteins.  After the tissue is fixed, it is then dehydrated and embedded with 
wax, which provides structural support for the soft tissue to allow thin sectioning and 
increases the shelf-life of the sample indefinitely.  Rapid freezing is another technique 
used to preserve and prepare samples for imaging.  While the shelf life of frozen 
sections, as well as the structural quality of the tissue, is not comparable to formalin-
fixed, paraffin-embedded (FFPE) tissues, frozen sectioning can be done very rapidly, 
allowing the technique to be used during a surgical procedure.  More recent sample 
acquisition techniques, such as imaged-guided fine needle aspiration (FNA), have 
allowed the collection of small samples without the need for surgery, allowing clinicians 
to diagnose patients in an inexpensive and rapid fashion.   
 In addition to advances in tissue sample acquisition techniques, the early 
development of staining procedures significantly contributed to the use of histology in the 
clinic.  The most notable of these is the use of hematoxylin and eosin (H&E) stains for 
providing contrast in tissues [213-215].  H&E staining is probably the most widely used 
stain in diagnostic medicine and is routinely used for the examination of cancer biopsies 
as well as many other diseased tissue samples.  The H&E procedure involves staining 
with a basic dye (hematoxylin), which stains basophilic components a bluish purple 
color, and an acidic dye (eosin), which stains eosinophilic components a pink color.  
Because it is a basic molecule, hematoxylin generally stains acidic structures within the 
cells and tissue, such as the nucleus and ribosomes, because of the large prevalence of 
nucleic acids.  Likewise, eosin preferentially stains basic structures or regions, such the 
cell cytoplasm, due to the presence of protein.  These stains provide pathologists with a 
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high degree of contrast for examining tissue structure (as seen in Figure 7.1a) and 




Figure 7.1. Standard staining procedures, shown on liver cancer tissue sections.  (a) 
Hematoxylin and eosin (H&E) staining, which colors basophilic components bluish-
purple (from hematoxylin) and eosinophilic components pink. (b) Immunohistochemistry 
(IHC) staining of a liver cancer biomarker using antibodies (for targeting) and 
horseradish peroxidase, which oxidizes a substrate to yield a brown stain. 
 
 Further progress in the diagnosis of disease using histopathology was seen 60 
years ago with the introduction of immunohistochemistry (IHC) [216, 217].  This 
technique originally involved the use of fluorescently tagged antibodies to target and 
image proteins of interest within tissue samples.  However, early versions of this 
technique were plagued with many problems, including high autofluorescence that 
significantly masked the signal, low photostability of the dyes which eventually render 
the sample unmeasurable and the difficulty and expense of using the necessary 
instruments to analyze the samples.  In an effort to alleviate these problems, a new 
labeling technique was developed that allowed the visualization of the targeted 
molecules using standard light microscopes [218-221].  This technique uses enzyme-
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linked antibodies (horseradish peroxidase, HRP, is the most commonly used today) to 
produce a signal visible under microscopy.  After binding of the antibodies to the 
targeted molecules in the sample, a substrate is applied which can be oxidized by HRP 
to yield a visible stain.  As shown in Figure7.1b, this leads to a stable, dark product that 
is easily visible using a standard microscope.  This technique is now a standard 
procedure used in both research labs as well as the clinic for identifying proteins of 
interest. 
 The adoption of this technique by clinicians has revolutionized the field of 
histopathology, allowing pathologists to probe diseased tissue samples on the molecular 
level and more accurately diagnose diseases.  This procedure has been particularly 
useful in oncology, where a number of important biomarkers have been identified for 
many cancer types.  One such example is Her2, a surface receptor protein 
overexpressed in 25 to 30 percent of breast cancers, which can be targeted very 
effectively with humanized monoclonal antibodies, resulting in a significantly increased 
survival rate [222].  To determine which patients can benefit from this therapy, a 
diagnostic test (Herceptest) was developed to enable pathologists to estimate the level 
of Her2 expression based on analysis of the biopsy sample [223, 224].  In addition, other 
biomarkers, such as the estrogen receptor (ER) and progesterone receptor (PR) have 
been shown to indicate the aggressiveness of a particular cancer and the survival rate of 
the patient for various therapeutic strategies.  These important proteins form a 3 
biomarker panel that is now routinely used in the diagnosis of breast cancer patients and 
in the selection of treatment options [225-227]. 
 However, preparation and analysis of these samples is time consuming and must 
be performed on separate sections, requiring a large amount of sample and increasing 
variability in the results.  Additionally, analysis of the samples requires the eye of a 
trained and experienced pathologist and is subjective or semi-quantitative at best.  QDs 
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have many properties that make them ideal as an optical imaging agent for use in 
clinical diagnostics.  Of particular note, multiple QD colors can be excited using a single 
excitation source, allowing for the simultaneous measurement of multiple colors.  The 
QDs also have very narrow and uniform emission profiles which can be tuned, providing 
a number of colors to be used in the multiplexed assays.  Because of these unique 
properties, QDs present an exciting opportunity to develop the next generation of 
immunohistochemistry techniques.  The ability to image multiple colors simultaneously 
allows the use of QDs in multiplexed assays, where multiple biomarkers can be 
analyzed on a single tissue section, dramatically reducing the amount of tissue needed 
for a pathological analysis.  Newly developed instrumentation, such as CRI’s Nuance 
multispectral imaging system, can also allow pathologists to measure and separate QD 
signals in an objective and quantitative way, significantly increasing consistency and 
repeatability in diagnoses. 
 Preliminary work by our group and others has shown the utility of these 
fluorescent nanoparticles in ultrasensitive imaging of biomarkers in cells as well as 
tissues [53, 54, 99, 100].  These techniques provide dramatic multicolored images for 
the analysis of biomarker expression and localization, as seen in Figure 7.2.  Despite the 
early success of this technology, significant hurdles must be overcome before 
pathologists adopt this technology for use in clinical diagnostics.  As described in 
Chapters 2 and 6, nonspecific binding of QDs and other nanoparticles to components in 
blood, cells and tissues presents a considerable challenge to the use of these 
nanoparticles for ultrasensitive detection in complex biological samples.  This can 
significantly increase the background fluorescence and lead to false positive signals.   
This background also leads to degradation of the signal-to-noise ratio and limits tagging 






Figure 7.2. Multicolor staining of cells using quantum dots. (a) Nuclear (red) and 
microtubule (green) staining with streptavidin-coated quantum dots in NIH/3T3 cells. (b) 
Staining of SK-BR-3 breast cancer cells with streptavidin-coated quantum dots targeted 
against the nucleus (red) and Her2 surface receptors (green). From Wu et al [53]. 
 
 It is hypothesized that the use of nonstick hydroxyl-QDs described in chapter 6 
can eliminate these problems and improve the utility of QDs in these samples.  In this 
chapter, we investigate bioconjugation techniques for the coupling of antibodies or other 
targeting molecules to the surface of OH-QDs. 
 
7.3 METHODS 
Quantum Dot Stability in Acetonitrile 
 50 nM solutions of OH-QDs and COOH-QDs were prepared in water. The 
samples were vortexed and sonicated for 15 minutes to disperse any aggregates and 
filtered using a 0.2 μm filter to remove contaminants.  Separately, acetonitrile (ACN) was 
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diluted to different concentrations (from 0% to 75% ACN by volume) in water and 
transferred to glass vials.  Aliquots of the QD samples were pipetted into the ACN 
containing vials and were vortexed to completely mix the samples.  The fluorescence 
intensity of the samples was then measured and plotted as a function of ACN 
concentration. 
 
Effect of Cyanogen Bromide on Hydroxyl-Coated Quantum Dots 
 Purified OH-QDs and COOH-QDs were mixed with DI water, 15% ACN and 0.5 
M Cyanogen Bromide (CNBr) in 15% ACN.   Aliquots were then taken and analyzed 
using gel electrophoresis to determine differences in gel migration.  Separately, a 
concentration series of CNBr in 15 % ACN (1 M to 0.0001 M CNBr) was prepared in 
glass vials.  Aliquots of the OH-QD sample were pipetted into the vials and were 
vortexed to mix thoroughly.  The samples were then analyzed using gel electrophoresis 
and the migration shifts were measured and plotted as a function of CNBr concentration. 
 
Antibody Coupling to Hydroxyl Quantum Dots 
 Purified OH-QDs were diluted into a buffer containing 15% ACN.  The solution 
was cooled in an ice water bath and stirred vigorously to ensure the sample was well 
mixed.  Separately, a stock 0.5 M CNBr solution was prepared by diluting CNBr into 
ACN.  This solution was added dropwise to the QD solution under vigorous stirring to a 
final concentration of 0.0005 M CNBr and was allowed to react for approximately 2 min.  
A primary amine-containing targeting molecule (such as an antibody) was then added to 
the solution at a ratio of 25:1 targeting molecule : QD.  This solution was mixed and 
allowed to react at 4°C for 24 hours.  The sample was then purified using dialysis and 




Cell Labeling with Hydroxyl Quantum Dots 
 MDA MB 231 cells were cultured in RPMI media with 10% fetal bovine serum 
(FBS) at 37 ºC (5% CO2) and grown in an 8-well chamber slide.  After 24 hours for 
seeding, the cells were washed with 1X phosphate buffered saline (PBS) and fixed with 
3.7% formaldehyde in 1X PBS for 5 minutes.  The fixative was then aspirated and the 
cells were washed with 1X PBS 3 times for 5 min each.  A 0.1% Triton X solution in 1X 
PBS was then used to permeabilize the cells for 5 min, followed by 3 washes of 1X PBS.  
A 2% bovine serum albumin (BSA) blocking solution in 1X PBS was added to the wells 
for 1 hour and then aspirated.  A primary antibody solution was diluted into the blocking 
buffer to a final concentration of approximately 5 μg/mL and then applied to the cells for 
30 min.  Cells were then washed with 1X PBS 3 times for 5 min each.  Secondary 
antibody-conjugated QDs were diluted in the blocking solution to a concentration of 
approximately 10 nM and incubated with the cells for 30 min.  The QD staining solution 
was aspirated and the cells were washed with 1X PBS 3 times for 5 min each and 





7.4 RESULTS AND DISCUSSION 
Bioconjugation Strategies 
Many bioconjugation strategies have been used to couple targeting molecules, 
such as proteins, antibodies, nucleic acids and small molecules, to nanoparticle labeling 
agents.  These coupling strategies generally involve the covalent linkage of functional 
groups of the targeting molecule and groups on the surface of the nanoparticle.  Typical 
functional groups include thiols (which can be coupled to reactive maleimide groups), 
amines (which can be coupled to reactive succinimidyl esters such as NHS) and 
carboxylic acids, which are routinely coupled to amines though a reactive carbodiimide 
intermediate [228].  The most widely used bioconjugation procedure involves the use of 
EDAC, a water soluble carbodiimide compound that activates carboxylic acids to form 
amide bonds with free amine groups.  This technique has been used in a wide array of 
applications, including the crosslinking of molecules and the coupling of small molecule 
dyes to antibodies or other proteins.  It has also been extensively used in the coupling of 
targeting molecules to nanoparticles such as quantum dots [229]. 
Other strategies for attaching targeting molecules to the surface of a nanoparticle 
include noncovalent methods, such as the use of streptavidin and biotin.  This strategy 
typically involves coupling streptavidin (a 52.8 kDa protein) to the surface of the 
nanoparticle.  Subsequently, a targeting molecule attached to biotin (vitamin H, a small 
molecule which binds strongly to streptavidin) is added and is spontaneously coupled to 
the nanoparticle surface.  This bond is considered one of the strongest noncovalent 






Figure 7.3. Reaction scheme for coupling targeting molecules, such as antibodies, to 
hydroxyl-coated quantum dots using cyanogen bromide (CNBr). The CNBr forms a 
cyanate ester which can react with primary amines to form an isourea derivative. 
 
For the coupling of targeting molecules to the surface of nonstick, hydroxyl-
modified QDs, a strategy was needed that could couple the hydroxyl functional groups 
on the surface of the nanoparticle to free amines, which are prevalent on antibodies and 
other proteins as well as modified nucleic acids and many small molecules.  Cyanogen 
bromide (CNBr) was identified as a possible activating compound to aid in the 
bioconjugation of targeting molecules [230].  As shown in Figure 7.3, CNBr reacts with 
free hydroxyl groups to form a highly reactive cyanate ester which can react with free 
amines to yield an isourea linkage.  Because this procedure is typically carried out in 
acetonitrile (ACN), it was necessary to ensure the optical and colloidal stability of OH-
QDs is maintained in buffers containing this solvent. 
 
Quantum Dot Stability in Coupling Buffer 
 To verify the optical and colloidal stability of polymer-coated QDs in ACN, a 
sample was prepared in water and filtered to remove any aggregates or contaminants.  
Aliquots were then taken and diluted into buffers containing increasing percentages of 
ACN to determine if this resulted in the precipitation of the nanoparticles.  Little to no 
precipitation was seen in the samples (both OH-QDs and COOH-QDs) for ACN 
concentrations as high as 75% by volume.  The samples were then analyzed using a 
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spectrofluorometer to determine if the nanoparticles’ bright fluorescence was 
maintained.  As shown in Figure 7.4a, the fluorescence properties of the QDs were 
unaffected in solutions with ACN concentrations of 40% or less.  Increasing the 
concentration of ACN above 40 % resulted in a steady decline in the fluorescence 
intensity, with over 80% of the intensity lost in solutions containing 75% ACN.   
 
 
Figure 7.4. Polymer coated quantum dots in acetonitrile.  (a) Normalized quantum dot 
fluorescence as a function of the percentage of acetonitrille.  Quantum dots were stable 
in solutions containing up to ~40% acetonitrile. (b) Gel migration of COOH and OH 
coated quantum dots.  Acetonitrile and 0.5 M cyanogen bromide (CNBr) had no effect on 
the migration of COOH quantum dots.  However, high concentrations of CNBr caused 
aggregation of OH quantum dots as a result of the reaction.  
 
Based on these results, a separate experiment was conducted to further examine 
the colloidal stability of QDs in the presence of ACN.  Samples of OH-QDs and COOH-
QDs were prepared and diluted into buffers for a final ACN concentration of 15%.  The 
samples were then vortexed to ensure sufficient mixing and analyzed using gel 
electrophoresis.  Samples containing CNBr were also analyzed to determine if this 
affected the stability of the nanoparticles.  As seen in Figure 7.4b, the presence of ACN 
had no affect on the stability of the QDs.  Both COOH-QDs (bottom) and OH-QDs (top) 
showed no shift in gel migration when compared to controls without ACN.  In contrast, 
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the presence of CNBr has a significant effect on the gel migration of QDs.  OH-QDs 
exposed to a solution containing 0.5M CNBr showed some aggregation and were unable 
to migrate in the gel.  However, no effect was seen for COOH-QDs exposed to CNBr 
(Figure 7.4b, bottom), which showed no difference in migration rates when compared to 
samples containing ACN and the control.  This difference is likely due to the reactivity of 
the CNBr, which is able to form cyanate ester intermediates with hydroxyl functional 
groups but is unreactive towards carboxylic acid groups, resulting in no change to their 
surface.   
 
Reactivity of Quantum Dots with Cyanogen Bromide 
 After verifying the optical and colloidal stability of QDs in the ACN reaction 
buffers, a study was performed to determine the effective concentration range for the 
reaction of CNBr with the surface hydroxyl groups of the QDs.  Dilutions of CNBr were 
made in ACN to prepare a concentration series from approximately 0.5 M to 0.0001 M 
CNBr.  Aliquots of OH-QDs were then added to the samples and mixed, as described 







Figure 7.5. Reactivity of Cyanogen Bromide (CNBr) with hydroxyl-coated quantum dots.  
(a) Gel shift of hydroxyl quantum dots as a function of CNBr concentration and (b) gel 
image.  Increasing CNBr concentrations results in a significant reduction in the gel 
migration of the nanoparticles as the CNBr reacts with the hydroxyl groups on the 
nanoparticle surface.  
 
 Gel analysis revealed a steady decline in gel migration as the concentration of 
CNBr increased, as expected from the results of the previous study.  Significant 
migration shifts were seen with CNBr concentrations from 0.05 M to 0.001 M, with 
concentrations higher than these values showing signs of aggregation and no gel 
migration.  Likewise, concentrations lower than 0.001 M showed no effect on the 
samples’ colloidal stability or gel migration in comparison to the control.  It is 
hypothesized that these lower concentration values result in the reaction of CNBr with 
the hydroxyl functional groups on the surface of the nanoparticles but do not alter the 
surface substantially or affect the overall surface charge of the QDs.  From previous 
studies (Chapter 3), we have estimated the total number of functional groups on the 
surface of the QDs to be approximately 2500 per particle.  This study suggests that a 
slight excess of CNBr, in comparison to surface functional groups, is needed to see 
effects on the overall surface charge.  Based on these results, we have used a final 
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concentration of 0.0005 M CNBr for coupling to antibodies to avoid significant changes 
the surface of the nanoparticles. 
 
Targeted Cell Staining using Quantum Dots 
 After determining the experimental parameters for reacting the hydroxyl 
functional groups of the OH-QDs with CNBr, coupling experiments were performed to 
attach secondary antibodies to the surface of the nanoparticles, as described in the 
methods section above.  Secondary antibodies are commonly used in current IHC 
staining procedures and were used in this study for future comparisons to standard 
staining protocols.  They also allow the production of a very versatile probe which can be 
used in conjunction with a wide variety of primary antibodies targeted against many 
markers of interest.  In addition, multiple secondary antibodies are able to bind to a 









Figure 7.6. Labeling of MDA MB 231 breast cancer cells using antibody-conjugated, 
hydroxyl quantum dots.  Fluorescence microscopy (registered with the cells by 
overlaying onto a bright field image) shows strong quantum dot staining of cells (red 
fluorescence). 
 
The antibody-targeted QDs were then used to stain MDA MB 231 breast cancer 
cells, as shown in Figure 7.6.  Whereas untargeted hydroxyl QDs show no detectable 
binding (Chapter 6), the targeted probes show moderate staining of the breast cancer 
cells.  These data show that the synthesis of a targeted QD with reduced nonspecific 
binding is possible.  These nanoparticles could have a significant impact on clinical in 






In this chapter, we have reported the development of a bioconjugation procedure 
for the coupling of antibodies or other targeting molecules to the surface of OH-QDs with 
significantly reduced nonspecific binding (Chapter6).  Data analysis shows that OH-QDs 
are optically and colloidally stable in buffers containing a moderate percentage of ACN 
and no gel migration shifts are seen.  Further studies have shown that CNBr reacts 
preferentially with nanoparticles containing hydroxyl functional groups on their surface 
(in comparison to carboxylic acid groups).  After performing antibody coupling 
experiments, preliminary staining results show a moderate staining in breast cancer 











8.1  ABSTRACT 
In this chapter, we summarize the work presented in the previous chapters and 
its implications for future nanotechnology applications in the medical field.  We also 
discuss future directions for continuing this work, specifically in ultrasensitive detection 
for diagnostic applications.   
 
8.2 SUMMARY 
This dissertation has focused on the design and development of polymer-coated 
nanoparticle imaging agents useful in biological environments, specifically diagnostic 
applications in cells, blood and tissue.  In particular, the challenges of early stage 
detection and diagnosis of cancer present opportunities for cancer nanotechnology to 
make a significant impact on the practice of medicine and in the lives of patients.  The 
ultrasensitive and multiplexed detection capabilities of semiconductor and metal 
nanoparticles could enable advanced diagnostic platforms for probing samples on the 
molecular level and detecting disease in its earliest stages, when treatment is most 
successful.  In the first chapter, we briefly described the field of nanotechnology and its 
implications for therapeutic and diagnostic applications.  We also discussed the complex 
and heterogeneous nature of cancer biology and the complications this presents to early 
stage diagnostics.  With recent advances in nanotechnology, diagnostic techniques and 
our understanding of new disease biomarkers, ―personalized medicine‖ is now within the 
realm of possibility.   
 In the second chapter of this dissertation, we further explored one class of 
nanoparticle, semiconductor nanocrystals (QDs), and the unique optical and physical 
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properties which make them promising for use in fundamental biology studies and other 
biomedical applications where ultrasensitive detection is needed.  In addition, we 
describe the considerable progress made in the synthesis of high quality nanoparticles 
as well as the coating and surface chemistry strategies that have been used for transfer 
to aqueous solutions.  These typically rely on the exchange of hydrophobic surface 
ligands for ones containing functional groups suitable for solubility in water or coating of 
the hydrophobic particles with an amphiphilic polymer or complex molecule.  Using these 
strategies, a number of preliminary biological studies have been performed, both in vitro 
and in vivo, although hurdles remain for their adoption in the clinic. 
 The third chapter presented the design and development of low molecular weight 
amphiphilic polymers for use in nanoparticle coating applications.  We discussed 
optimization of the polymer synthetic procedure as well as the nanoparticle coating and 
purification process.  The coated nanoparticles were then extensively analyzed using a 
variety of techniques to determine their optical and colloidal properties and ensure they 
were suitable for use in biological applications. 
 In the fourth chapter, we explored the use of these amphiphilic polymers as 
multidentate ligands for the synthesis of QDs.  It was shown that the polymers are 
capable of acting as cadmium precursor ligands and their use resulted in unique effects 
in the synthesis of the nanoparticles, including better control of the reaction kinetics, 
resistance to Ostwald ripening and the ability to produce ultrasmall particles.  The 
polymer also allowed for the in situ growth of an inorganic passivating shell to protect the 
nanocrystal surface and  bandgap engineering of the particles.  Finally, we showed that 
the use of an amphiphilic noncoordinating solvent, such as PEG, and an excess of 




 The fifth chapter presented further exploration of the use of polymers in 
nanoparticle synthesis.  Here, we reported a new synthetic procedure for the preparation 
of AuNPs using the multidentate polymers.  There were many novel features associated 
with this procedure, including significantly reduced growth kinetics, increased 
nanoparticle stability and the ability to produce a very wide range of particle sizes.  Upon 
the addition of reporter dyes to large AuNPs produced using this method, SERS-active 
particles were spontaneously formed in a on-pot method. 
 In the sixth chapter of this dissertation, we described the development of a new 
class of polymer-coated, hydroxylated QDs for use in clinical applications.  These 
nanoparticles had compact sizes and were shown to significantly reduce the nonspecific 
binding of QDs in cells.  Further studies revealed that surface charge plays a critical role 
in the nonspecific binding of nanoparticles to cellular structures as well as proteins and 
other components in biological fluids.  This technology could enable highly sensitive 
detection of markers in clinical applications. 
 Finally, the seventh chapter described the development of a bioconjugation 
procedure coupling targeting molecules such as antibodies, nucleic acids or small 
molecules to the surface of nonstick OH-QDs.  Upon coupling secondary antibodies to 
the QD surface, preliminary studies show staining in breast cancer cells, indicating the 
utility of these nanoparticles in a number of staining applications. 
 In summary, this dissertation has describe several improvements in the 
development of nanoparticles for use in biomedical applications, particularly in vitro 
diagnostics, and the results may further advance the understanding of nanoparticle 





8.3 FUTURE DIRECTIONS FOR DISSERTATION TECHNOLOGY 
As described above, the work discussed in this dissertation mainly focuses on 
nanoparticle development and the interactions of nanoparticles with biological samples.  
While the results here conclusively demonstrate the utility of these particles, further 
development is needed for the adoption of these novel technologies in clinical diagnostic 
applications.  Here, we discuss the future directions for this research and a number of 
studies that should be undertaken to progress the technologies. 
 
Optimization of SERS-active Gold Nanoparticles for Biological Studies 
 In chapter 5, we presented several proof-of-concept studies demonstrating a 
one-pot synthesis procedure for the preparation of water soluble, SERS-active AuNPs.  
As described earlier, SERS-active nanoparticles have shown considerable promise for 
use in diagnostic assays.  Because of the multi-peak nature of a SERS spectrum and 
the narrowness of the individual peaks, the multiplexing potential of SERS particles is 
significantly greater than the current generation of QDs.  In addition, AuNPs do not 
contain toxic elements and are more likely to be approved for use in in vivo diagnostic 
applications.  This work presents an opportunity to further develop highly sensitive 
probes using polymer-coated AuNPs.  In particular, the adsorption of the reporter dye 
and the effects of the polymer coating have not been completely understood in this 
system and additional research could lead to better synthetic procedures.  It is 
hypothesized that the thick polymer-coating on nanoparticles prevents a majority of the 
dye molecules from accessing the surface and producing a strong SERS signal.  The 
covalent linkage of reporter dyes to the polymer backbone could circumvent this 
limitation and result in significantly brighter signal.  Covalent linkage also offers the 
possibility of incorporating more than one dye on a single AuNP, in varying ratios, to 
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produce a SERS barcode technology to dramatically increase the multiplexing potential 
of these particles.  
 
Multiplexed Tissue Staining using Nonstick Quantum Dots 
 Significant developments were presented in this work showing the preparation of 
QDs that eliminate the nonspecific binding problems seen with other nanoparticles.  
Preliminary work was also presented that described the development of a bioconjugation 
strategy for these hydroxyl-coated nanoparticles and targeted cell staining.  Further 
studies should be conducted to optimize the staining protocols for imaging cells and 
tissue using these nonstick QDs.  Additional studies are needed to determine the 
multiplexing capability of the OH-QDs.  It is hypothesized that the reduction of 
nonspecific binding of QDs to tissue will dramatically increase the sensitivity and 
specificity of the targeted staining.  A direct comparison should be performed against 
commercially available QDs to determine if there is any increase in multiplexing ability 
using OH-QDs and determine the lower limit of detection for these novel nanoparticles.  
Direct comparison studies should also be conducted using the nonstick QDs and 
standard IHC staining procedures to show this technology is as good or superior to the 
clinical gold standard for histopathology. 
 
Ultrasensitive Detection of Rare Cells in Fluid Samples 
 One application not discussed in this dissertation is the detection of rare cells in 
fluid samples such as blood, serum or pleural fluid.  The study of circulating tumor cells 
(CTCs) and developments of technology to detect them in clinical patients has been an 
area of intense research over the past few years.  The detection of these cells could 
allow for the detection of cancer before metastasis has occurred, dramatically increasing 
the chances of successful treatment.  Early attempts to detect these cells have involved 
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the use of magnetic particles to trap and magnetically isolate the CTCs from normal cells 
in the sample.  These separation procedures take time and add additional steps to the 
process, which could decrease the recovery rate of the cells.  For rare cells such as 
CTCs, even small losses could dramatically reduce the detection sensitivity, reducing 
the effectiveness of the assay.  With the development of ultrasensitive QDs with bright 
fluorescence and reduced background staining described in this dissertation, a detection 
method that bypasses these additional separation steps may be possible, improving 
sensitivity.  Studies should be conducted to determine the nonspecific binding of OH-
QDs in these samples and the lower detection limit for indentifying CTCs using nonstick 
QDs targeted the cells. 
 
8.4 CONCLUSIONS 
In conclusion, we have summarized the work discussed in this dissertation and 
described several future directions for the continuation of this research and the further 
development of these technologies.  This work has made a number of contributions in 
the design and development of polymer-coated nanoparticles for use in biological 
systems as well as furthered the understanding of nanoparticle interactions with 
components in cells, tissues and biological fluids.  The developments presented here will 
prove significant in the translation of these and other technologies to the clinic and the 
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